SCHEDULE 14A
(RULE 14A-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES
EXCHANGE ACT OF 1934 (AMENDMENT NO.1)
Filed by the Registrant [X]
Filed by a Party other than registrant [_]
Check the appropriate box:
[X] Preliminary proxy statement. [_] CONFIDENTIAL, FOR USE OF THE
COMMISSION ONLY (AS PERMITTED BY
RULE 14A-6(E)(2)).
[_] Definitive proxy statement.
[_] Definitive additional information.
[_] Soliciting material pursuant to Rule 14a-11(c) or Rule 14a-12.
NAVA LEISURE USA, INC.
- --------------------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)
- --------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of filing fee (Check the appropriate box):
[_] No fee required
[X] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
(1) Title of each class of securities to which transaction applies:
Common Stock
- --------------------------------------------------------------------------------
(2) Aggregate number of securities to which transaction applies:
1,700,000
- --------------------------------------------------------------------------------
(3) Per unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is
calculated and state how it was determined):
$.0005 The fee was calculated based on the par value of the securities which are
being issued pursuant to the Merger.
- --------------------------------------------------------------------------------
(4) Proposed maximum aggregate value of transaction:
$283.33
- --------------------------------------------------------------------------------
(5) Total fee paid:
- --------------------------------------------------------------------------------
[X] Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the offsetting
was paid previously. Identify filing by registration statement
number, or the form or schedule and the date of its filing.
(1) Amount Previously Paid:
$.06
- --------------------------------------------------------------------------------
(2) Form, Schedule or Registration Statement No.:
Schedule 14A
- --------------------------------------------------------------------------------
(3) Filing Party:
Nava Leisure USA, Inc.
- --------------------------------------------------------------------------------
(4) Date Filed:
October 16, 1998
- --------------------------------------------------------------------------------
NAVA LEISURE USA, INC.
December _______, 1998
Dear Shareholder of Nava Leisure USA, Inc.
You are invited to attend a Special Meeting of the Shareholders of Nava
Leisure USA, Inc.(the "Company") to be held on December _____, 1998 at 10:00
a.m. local time, at the________________________________________________ (the
"Special Meeting").
At the Special Meeting, you will be asked to consider and vote upon several
proposals, all of which relate to the acquisition through a merger (the
"Merger") by the Company of Senesco, Inc. ("Senesco"), the reorganization of the
Company (the "Reorganization") and the financing of the ongoing operations of
the Company following the Merger. Prior to completing the Merger, the Company
anticipates effecting a three shares-for-one share reverse stock split (the
"Reverse Split") to reduce the number of outstanding shares of its common stock,
par value $.0005 per share ("Common Stock"), from 3,000,025 to approximately
1,000,008. The Company would then issue an aggregate of 1,700,000 shares of
post-Reverse Split Common Stock to the shareholders of Senesco in exchange for
their shares of common stock in Senesco and Senesco would be merged with and
into Nava Leisure Acquisition Corp., a wholly-owned subsidiary of the Company
formed for the purpose of effecting the Merger. Following consummation of the
Merger, the Company will change its name to "Senesco Technologies, Inc." and
anticipates reincorporating in Delaware and conducting one or more financing
transactions as contemplated in Senesco's Business Plan; in the interim, Senesco
has arranged for bridge financing (the "Bridge Loan"), provided by South Edge
International Limited, in an amount of up to $500,000; of such amount
approximately $164,000 has been drawn down to date and the remainder is expected
to be drawn down by the Company on a monthly basis following the consummation of
the Merger; you will also be asked to ratify all corporate action by Senesco
and/or the Company with respect to the Bridge Loan. Summaries of the principal
terms and conditions of the Merger, the Reverse Split, the Reorganization, the
Bridge Loan and various corporate actions incident thereto are included in the
accompanying Proxy Statement. Please review and consider the enclosed materials
carefully.
Your Board of Directors has unanimously approved the terms and conditions
of the Merger Agreement and Plan of Merger, dated October 9, 1998 and amended as
of December ________, 1998, among the Company, Nava Leisure Acquisition Corp.
and Senesco setting forth the terms of the Merger as well as the related
Reorganization. THE BOARD OF DIRECTORS OF THE COMPANY BELIEVES THAT THE PROPOSED
MERGER, THE REORGANIZATION AND THE BRIDGE LOAN ARE IN THE BEST INTERESTS OF THE
COMPANY AND ITS SHAREHOLDERS AND UNANIMOUSLY RECOMMENDS THAT YOU VOTE FOR
---
APPROVAL AND ADOPTION OF THE MERGER, THE REVERSE SPLIT , THE REORGANIZATION, THE
BRIDGE LOAN AND THE OTHER PROPOSALS SET FORTH IN THE PROXY STATEMENT.
Regardless of the number of shares you hold or whether you plan to attend
the Special Meeting, we urge you to complete, sign, date and return the enclosed
proxy card immediately. If you attend the Special Meeting, you may vote in
person if you wish, even if you have previously returned your proxy card.
Sincerely,
1
NAVA LEISURE USA, INC.
NOTICE OF SPECIAL MEETING OF SHAREHOLDERS
TO BE HELD ON DECEMBER ____,1998
NOTICE IS HEREBY GIVEN that a Special Meeting of Shareholders of Nava
Leisure USA, Inc., an Idaho Corporation (the "Company"), will be held on
December ____, 1998, at 10:00 a.m. local time, at _____________________________,
for the following purposes:
1. To consider and vote upon a proposal to acquire Senesco, Inc.
("Senesco"), a New Jersey corporation, through the merger (the "Merger") of
Senesco into Nava Leisure Acquisition Corp. ("Acquisition Corp."), a New Jersey
corporation and a wholly-owned subsidiary of the Company formed for the purpose
of effecting the Merger. Following a three shares-for-one share reverse split
with respect to the outstanding shares of common stock par value, $.0005 per
share, ("Common Stock") of the Company (the "Reverse Split"), in consideration
of the agreement of the shareholders of Senesco to surrender their shares of
common stock no par value, of Senesco ("Senesco Common") in the Merger, the
Company will issue an aggregate of 1,700,000 shares of its authorized but
previously unissued Common Stock to the shareholders of Senescoon a pro rata,
--- ----
one share-for-one share basis as per the terms more completely
described in the accompanying Proxy Statement, the Merger Agreement and Plan of
Merger, dated October 9, 1998 and amended as of December ______, 1998, by and
among the Company, Senesco and Acquisition Corp. (the "Merger Agreement") and
the Letter of Intent, dated October 2, 1998, between the Company
and Senesco;
2. To approve the Reverse Split;
3. To consider and vote upon a proposal to amend the Articles of
Incorporation of the Company to change the name of the Company to "Senesco
Technologies, Inc." in order to more accurately describe the new business of the
Company;
4. To consider and vote upon a proposal to amend the By-laws of the
Company to create two classes of directors; Class A to consist of four (4)
directors, each elected to a one-year term, and Class B to consist of one (1)
director, elected to a two-year term;
5. To elect three (3) members to the Company's Board of Directors, two of
whom shall be considered Class A Directors and shall serve until the next Annual
Meeting of Shareholders or until their successors are duly elected and
qualified, and one of whom shall be considered a Class B Director and shall hold
office for a term of two years or until his successor is duly elected and
qualified;
6. To consider and vote upon the proposal to reincorporate the Company in
the State of Delaware;
7. To ratify the terms of a Loan Agreement, dated October 22, 1998,
between Senesco and South Edge International Limited, providing for up to
$500,000 in bridge financing, approximately $164,000 of which has been drawn
down by Senesco to date and the remainder of which is expected to be drawn down
by the Company on a monthly basis following completion of the Merger, in order
to fund operations during the interim period following the Merger until the
earlier of: (a) completion of a future offering of the Company's securities as
contemplated in Senesco's Business Plan; or (b) October 22, 1999; such bridge
financing to bear interest at an annual rate equal to the prime rate plus
2%;
8. To ratify the adoption by the Company's Board of Directors of a Stock
Option Plan;
9. To approve the appointment of Goldstein Golub Kessler & Co., P.C. as
auditors of the Company for the fiscal year ending June 30, 1999; and
10. To consider and vote upon any and all other business that may properly
come before the Special Meeting of Shareholders.
The foregoing items of business are more fully described in the Proxy
Statement accompanying this Notice.
ONLY SHAREHOLDERS OF RECORD AT THE CLOSE OF BUSINESS ON NOVEMBER
_____, 1998 ARE ENTITLED TO NOTICE OF AND TO VOTE AT THE SPECIAL
MEETING OF SHAREHOLDERS AND AT ANY ADJOURNMENTS THEREOF.
YOUR VOTE IS IMPORTANT. ACCORDINGLY, PLEASE SIGN, DATE AND RETURN
THE ENCLOSED PROXY IMMEDIATELY TO ASSURE THAT YOUR SHARES ARE
REPRESENTED AT THE SPECIAL MEETING OF SHAREHOLDERS WHETHER OR NOT
YOU INTEND TO ATTEND THE MEETING.
BY ORDER OF THE BOARD OF DIRECTORS
J. Rockwell Smith, President
December _____, 1998
NAVA LEISURE USA, INC.
253 ONTARIO #1
P.O. BOX 3303
PARK CITY, UTAH 84060
(801) 649-5060
PROXY STATEMENT
THIS PROXY STATEMENT, which is first being mailed to shareholders on or
about December ____, 1998, is being furnished in connection with the
solicitation of proxies; ("Proxies") by the Board of Directors of Nava Leisure
USA, Inc., an Idaho corporation (the "Company") such Proxies to be voted at the
Special Meeting of Shareholders to be held on December ____, 1998, at 10:00 a.m.
local time, at ___________ and at any adjournments or postponements thereof.
At the Special Meeting, the holders of shares of common stock, par value
$.0005 per share ("Common Stock"), of the Company will be asked to consider and
vote upon a proposal for the Company to acquire the business of Senesco, Inc., a
New Jersey corporation (such corporation, as well as the surviving entity
following the Merger, being referred to herein as, "Senesco"), through the
merger (the "Merger") of Senesco into Nava Leisure Acquisition Corp. (the
Acquisition Corp."), a New Jersey corporation and a wholly-owned subsidiary of
the Company established for the purpose of effecting the Merger. Approval by the
shareholders of the Company is a condition to the consummation of the Merger. In
addition, holders of Common Stock will be asked to consider and vote upon a
related proposal to effect a reverse split with respect to the outstanding
shares of Common Stock (the "Reverse Split") prior to Merger. It is proposed
that each shareholder of the Company receive one share of Common Stock for every
three shares of Common Stock owned of record as of the record date for the
Reverse Split. In exchange for the agreement of the shareholders of Senesco to
surrender their shares of capital stock of Senesco in the Merger, the
shareholders of Senesco will receive an aggregate 1,700,000 shares of the
Company's authroized but unissued post-Revise Split common stock on a pro rata,
--- ----
one share-for-one share basis. There are currently 1,700,000 shares of Common
Stock of Senesco outstanding.
Following consummation of the Merger: (1) Acquisition Corp. will succeed to
the business of Senesco; (2) Acquisition Corp. will change its name to "Senesco,
Inc."; (3) the Company will change its name to "Senesco Technologies, Inc."; (4)
the Company will change its state of incorporation to Delaware; and (5) the
existing Directors of the Company will resign and be replaced by the Directors
elected by the shareholders of the Company at the Special Meeting.
Following consummation of the Merger, the Company also anticipates
conducting one or more offerings of its securities to raise financing for the
development and expansion of Senesco's business, as contemplated in Senesco's
Business Plan. Neither the Company nor Senesco currently has any formal
agreement, arrangement or understanding with any third party with respect to
such financing. In order to fund expenses associated with the Merger and fund
the ongoing operations of Senesco's business in the interim, on October 22, 1998
Senesco entered into a Loan Agreement
with South Edge International Limited, providing for up to $500,000 in financing
(the "Bridge Loan"). The Bridge Loan is evidenced by a Promissory Note (the
"Note"), bearing interest at an annual rate equal to the prime rate plus 2%, and
will become due and payable in full on the date of the earlier to occur of: (a)
such date (if any) following the completion of the Merger on which the Company
shall consummate an offering and sale of equity or convertible debt securities
which yields more than $500,000 in gross proceeds, and (b) October 22, 1999.
Upon consummation of the Merger, the Note will become a liability of the
Company. To date, Senesco has drawn down approximately $164,000 under the Bridge
Loan; the Company anticipates drawing down the remainder of the Bridge Loan on a
monthly basis following consummation of the Merger.
The voting securities of the Company consist of Fifty Million (50,000,000)
authorized shares of Common Stock, of which 3,000,025 shares were issued and
outstanding at the close of business on June 30, 1998 and approximately
1,000,008 shares will be outstanding after the Reverse Split. The Company
currently has no other class of voting security outstanding. Senesco's current
capitalization consists of 2,000,000 authorized shares of common stock, no par
value of which 1,700,000 shares are currently outstanding ("Senesco Common").
There is currently no public trading market for the outstanding shares of
Senesco Common.
Upon the consummation of the Merger, an aggregate of 1,700,000 shares of
Common Stock (i.e., one share of Common Stock for each outstanding share of
Senesco Common) will be issued to the shareholders of Senesco, resulting in a
total if approximately 2,700,008 shares of Common Stock outstanding. At such
time, the aggregate ownership interest of the current shareholders of the
Company will decrease from 100% to approximately 37% of the issued and
outstanding Common Stock and Senesco's shareholders will collectively own a
controlling interest in the Company. The ownership of the Company's current
shareholders would be further diluted upon the issuance of shares of Common
Stock in the event of a public or private offering of Common Stock or
convertible securities to raise additional financing for the Company's
operations. The Company currently has no formal plans to conduct such an
offering.
Only shareholders of record at the close of business on November _____,
1998, the record date for the Special Meeting (the "Record Date"), will be
entitled to notice of and to vote at the Special Meeting. Holders of record of
Common Stock on the Record Date are entitled to one vote per share, exercisable
in person or by proxy. The presence in person or by Proxy of a majority of the
outstanding shares of Common Stock entitled to vote is necessary to consititute
a quorum at the Special Meeting of Shareholders. Assuming a quorum is present,
the affirmative votes of the holders of a majority of the shares of Common Stock
outstanding, present in person or represented by Proxy, is required for approval
of each of the proposals to be voted upon at the Meeting. Shareholders do not
have cumulative voting rights.
Idaho Law treats abstentions as counting towards the determination of
whether a quorum is present at the Special Meeting of Shareholders. Abstentions
will not, however, be counted towards, or affect the outcome of, the vote on a
proposal; a proposal (other than for the election of Directors) will be deemed
approved if more votes are cast "for" the action than "against" the action.
2
Directors are elected by a plurality of the votes cast by the shares
entitled to vote when there is a quorum; those nominees with the most votes are
considered elected.
All Proxies received pursuant to this solicitation will be voted at the
Special Meeting of Shareholders and at any adjournments thereof as indicated in
the accompanying Proxy card. If the Proxy is properly executed and returned, the
shares it represents will be voted at the Special Meeting of Shareholders in
accordance with the instructions noted thereon. If no instructions are given,
the Proxy will be voted FOR all of the proposals presented and FOR the election
--- ---
of each of the three nominees for Director. Any shareholder executing the
attached Proxy card may revoke it at any time before it is voted: (a) by
submitting a duly executed Proxy bearing a later date; (b) by giving written
notice of revocation to the Secretary of the Company; or (c) by attending the
Special Meeting of Shareholders and orally withdrawing the Proxy.
Management knows of no other matter to be brought before the Special
Meeting of Shareholders not referred to in this Proxy Statement; if, however,
other matters properly come before the Special Meeting of Shareholders, a Proxy
will be voted in accordance with the judgment of the person voting such Proxy,
unless the Proxy indicates otherwise.
This Proxy Statement contains summaries of the terms and conditions of
certain agreements relating to the Merger, the Bridge Loan and the expansion of
Senesco's business. Reference is made to the specific terms of such agreements.
Copies of the following documents will be available for inspection at the
Special Meeting of Shareholders:
1. Merger Agreement and Plan of Merger, dated October 9, 1998 and amended
as of December ____, 1998, among the Company, Acquisition Corp. and
Senesco.
2. Letter of Intent dated October 2, 1998 between the Company and Senesco.
3. Business Plan of Senesco, dated __________________.
4. Loan Agreement, dated October 2, 1998, between the Company and South
Edge International Limited.
5. 1998 Stock Option Plan.
NO PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE ANY
REPRESENTATIONS NOT CONTAINED IN THIS PROXY STATEMENT AND, IF GIVEN OR MADE,
SUCH INFORMATION OR REPRESENTATIONS MUST NOT BE RELIED UPON AS HAVING BEEN
AUTHORIZED BY THE COMPANY. NO STATEMENT OF FACT HEREIN SHALL BE DEEMED TO
CREATE ANY IMPLICATION THAT SUCH FACTS HAVE NOT CHANGED SINCE THE DATE HEREOF.
THE DATE OF THIS PROXY STATEMENT IS DECEMBER ____, 1998
3
ACTION TO BE TAKEN AT THE MEETING
PROPOSAL 1
MERGER OF SENESCO, INC. INTO ACQUISITION CORP.
THE MERGER
On October 9, 1998, the Company and its wholly-owned subsidiary,
Acquisition Corp., entered into the Merger Agreement, pursuant to which Senesco,
Inc., a New Jersey corporation with principal offices at 11 Chambers Street,
Princeton, New Jersey 08542, (609) 252-0680, will merge with and into
Acquisition Corp., with Acquisition Corp. as the surviving entity (the
"Merger"). Acquisition Corp. shall change its name to Senesco, Inc. and shall
remain a wholly-owned subsidiary of the Company. As consideration for the
Merger, the Company will issue an aggregate of 1,700,000 shares (the "Merger
Shares") of its authorized but previously unissued Common Stock to the current
shareholders of Senesco. All of the Merger Shares to be issued under the Merger
Agreement shall be issued pursuant to exemptions from registration contained in
Sections 4(2) and 4(6) of the Securities Act of 1933, as amended (the "Act");
accordingly, all of such shares will be "restricted securities" pursuant to Rule
144 under the Act. The Merger Shares are being offered only to shareholders of
record of Senesco as of the effective date of the Merger. Senesco currently has
13 shareholders of record, all of whom the Company believes are either
"accredited investors" within the meaning of Rule 501 of Regulation D or are
sophisticated investors with prior experience in evaluating investments such as
the Merger Shares. Following consummation of the Merger the Company, through
Acquisition Corp., will own and operate the current business of Senesco.
Copies of the Letter of Intent between Senesco and the Company dated
October 2, 1998 (the "Letter of Intent") with respect to the Merger, the Merger
Agreement and Senesco's Business Plan will be available at the Meeting.
CAPITALIZATION
The Company's authorized capital consists of 50,000,000 shares of Common
Stock and 5,000,000 shares of Preferred Stock, $.001 par value per share
("Preferred Stock"). The Board of Directors has the authority to issue the
Preferred Stock in one or more series and to determine by resolution the
designation, relative rights and preferences of any such series.
There are currently 3,000,025 shares of Common Stock issued and
outstanding. Prior to consummation of the Merger, the Company will effect a
reverse split with respect to the outstanding Common Stock (the "Reverse
Split"), pursuant to which each shareholder of record of the Company as of the
record date for the Reverse Split will receive one share for every three shares
of Common Stock then held of record. After the Reverse Split, there will be
approximately 1,000,008 shares of
4
Common Stock issued and outstanding. (See "Proposal 2 - Reverse Stock Split").
There are currently no shares of Preferred Stock issued and outstanding.
Upon consummation of the Merger, the Company will issue an aggregate of
1,700,000 shares of Common Stock to the shareholders of Senesco on a pro rata,
--- ----
one share-for-one share basis; accordingly, upon consummation of the Merger,
there will be a total of approximately 2,700,008 shares of Common Stock
outstanding. As a result of the Merger, the aggregate ownership interest of the
current shareholders of the Company will be decreased from 100% to approximately
37% of the then issued and outstanding Common Stock and the 13 existing
shareholders of Senesco will own a controlling interest in the Company. There is
no public trading market for Senesco's outstanding capital stock.
BUSINESS OF SENESCO, LLC
OVERVIEW
Senesco, Inc. was incorporated in New Jersey on November ____, 1998 under
the name, "Senesco of New Jersey, Inc." and is the successor entity to Senesco,
LLC, a New Jersey limited liability company which was formed in June 1998
("Senesco LLC"). In November 1998, Senesco and Senesco LLC entered into an
Agreement and Plan of Merger pursuant to which Senesco LLC merged with and into
Senesco, with Senesco as the surviving entity. The primary business of Senesco
is the development and commercial exploitation of potentially significant
technology in connection with the identification and characterization of a gene
(a lipase gene) which controls the aging (senescence) of plants (flowers, fruits
and vegetables).
Senesco has formulated a Phase One Research and Development Plan to attempt
to further characterize the gene in flowers, fruits and vegetables. Senescence
in plant tissues is the natural aging of these tissues. Loss of cellular
membrane integrity attributable to lipase gene activity is an early event during
the senescence of all plant tissues that prompts the deterioration of fresh
flowers, fruits and vegetables. This loss of integrity is attributable to the
formation of lipid metabolites in membrane bilayers that "phase-separate" and
causes the membranes to become "leaky". A decline in cell function ensues
leading to deterioration and eventual death (spoilage of the tissue).
Presently, the technology utilized for controlling senescence and
increasing the shelf life of flowers, fruits and vegetables relies on reducing
ethylene biosynthesis, and hence only has application to a limited number of
plants that are ethylene-sensitive. Senesco is researching a plan to avoid this
limitation since Senesco believes that the lipase gene is present in all plants.
Senesco's "Phase One" research and development plan focuses on three major
groups of consumer products: fruits, vegetables, and flowers. Senesco plans to
isolate and characterize the lipase gene in an example from each of these three
categories. Once a gene is characterized, Senesco plans to create a transgenic
(i.e., genetically altered) example of each to show proof of concept in
5
each category. Phase One is presently focusing on tomato, carnation, green bean,
soybean, arabadopsis and banana.
Senesco anticipates entering into a joint venture (the "Joint Venture")
with Rahan Meristem, an Israeli company engaged in the worldwide export
marketing of genetically engineered banana fruit. Senesco would contribute
access, by way of a limited, exclusive license to the Joint Venture, to its
technology, discoveries, inventions, know-how (patentable or otherwise),
biological isolates, methods, processes, test data and related information
pertaining to plant genes and their cognate expressed proteins that are induced
during senescence (plant aging) for the purpose of developing, on a joint basis,
genetically altered banana seedlings, plants and other plant media which will
result in a "longer shelf life" banana. Rahan Meristem would contribute its
technology, inventions and know-how with respect to banana fruit. The Joint
Venture would be owned 50% by Senesco and 50% by Rahan Meristem. Negotiations
regarding the Joint Venture are well in progress, with a second draft proposal
currently under review. Management believes that the parties are in substantial
agreement on all major business and related issues.
The inventor of Senesco's technology, John E. Thompson, Ph.D., is Dean of
Science at the University of Waterloo in Waterloo, Ontario. Dr. Thompson is also
a shareholder of Senesco and owns approximately 25% of the outstanding shares of
Senesco Common. Senesco is currently negotiating a three-year research and
development agreement with Dr. Thompson and the University of Waterloo.
Management believes that such negotiations are in the final stages, with only
minor issues remaining open. In addition, Senesco has entered into a consulting
agreement with Dr. Thompson (the "Consulting Agreement") providing for Dr.
Thompson to render consulting services to Senesco in the field of controlling
senescence in living cells, including research, development, perfection and
testing. Pursuant to the Consulting Agreement, (1) Dr. Thompson has agreed not
to undertake any competing assignments, to keep all technical information
developed confidential and to disclose to Senesco any inventions and/or
improvements which arise from research performed pursuant to the Consulting
Agreement, and (2) Senesco has agreed to reimburse Dr. Thompson for all living
and travel expenses incurred by Dr. Thompson when traveling at Senesco's
request.
Dr. Thompson and his colleagues, Yuwen Hong and Katalin Hudak, filed a
patent application (the "Patent Application") on June 26, 1998 to protect their
invention, "A Plant Lipase Exhibiting Senescence-Induced Expression and a Method
for Controlling Senescence in a Plant." By assignment dated June 25, 1998 and
recorded by the United States Patent and Trademark Office on June 26, 1998, Dr.
Thompson and Messrs. Hong and Hudak assigned all of their rights in and to the
Patent Application and any other applications filed in the United States or
elsewhere with respect to the invention and/or improvements thereto to Senesco,
LLC. Senesco succeeded to the assignment, and owenership of the Patent
Application, upon the merger of Senesco, LLC with and into it. The invention
includes a method for controlling senescence of the cDNA for a carnation petal
lipase, a vector containing a cDNA for the carnation petal lipase, and a
transformed microorganism expressing the lipase of cDNA. Management believes
that the invention provides a means for delaying deterioration and spoilage,
which could greatly increase the shelf-life of fruits, vegetables, and flowers
by silencing or substantially repressing the expression of the lipase gene
6
induced coincident with the onset of senescence. There can be no assurance that
patent protection will be granted with respect to the Patent Application or
that, if granted, the validity of such patent will not be challenged.
Furthermore, although the Company believes that Senesco's technology is unique
and will not violate or infringe upon the proprietary rights of any third party,
there can be no assurance that no such claims will be made or if made, could be
successfully defended against.
COMPETITION
Senesco's competitors in the field of plant senescence gene technology are
companies that develop and produce transgenic plants. Such companies include:
Archer Daniels Midland, Inc.; Monsanto Corporation and its subsidiaries;
Agritope Inc.; Dekalb Genetics; American Cyanamid; ArgEvo; Cargill; DNAP
Holding Corporation; and Garst Seed Company, among others. The Company believes
that Senesco's proprietary technology is unique and that, therefore, its
competitors' products will not be in direct competition with Senesco's; however,
there can be no assurance that Senesco's competitors will not develop a similar
product with superior properties or greater cost-effectiveness than the
Company's. Furthermore, many of Senesco's competitors have greater financial and
other resources available to them that the Company and, as such, may be
available to research and develop, and/or effectively, market, competing
products sooner than the Company.
GOVERNMENT REGULATION
At present, no governmental license or approval is necessary for the
conduct of senescence gene research and development. Approval by the Federal
Food and Drug Administration (the "FDA") is required in order to sell or offer
for sale to the general public a genetically engineered plant or plant product.
The Company believes that Senesco's current activities, which to date have
been confined to research and development efforts, do not and will not require
licensing or approval by any governmental regulatory agency until such time as
Senesco has developed a marketable genetically engineered plant for use by the
general public. Government regulations are, however, subject to change and, in
such event, there can be no assurance that Senesco may not be subject to such
regulation or require such licensing or approval in the future. In addition,
products developed by Senesco will require FDA approval prior to being marketed
and sold for use by the general public. There can be no assurance that such
approval will be obtained in a timely manner, if at all.
EMPLOYEES
Senesco currently has three employees, all of whom are currently executive
officers and are involved in the management of Senesco. It is anticipated that
following completion of the Merger, all of such employees will continue as
employees of the Company. See "Proposal 4-Election of Directors and Increase In
The Number of Members of the Board of Directors - Significant Employees."
7
SUMMARY OF TERMS OF MERGER
The following summary of certain information contained in this Proxy
Statement does not purport to be complete and is qualified in its entirety by
more detailed information contained in the Merger Agreement, a copy of which is
attached hereto as Exhibit A, by references to Exhibit A hereto.
The Company proposes to merge Senesco with and into Acquisition Corp., with
Aquisition Corp. as the surviving entity. Acquisition Corp. would change its
name to "Senesco, Inc." and continue the business of Senesco following
completion of the Merger.
The closing of the transactions contemplated under the Merger Agreement is
presently scheduled to be held no later than five business days after the
Special Meeting of Shareholders.
ISSUANCE OF SHARES OF COMMON STOCK
The Company proposes to issue an aggregate of 1,700,000 Merger Shares to
the shareholders of Senesco, on a pro rata, one share-for-one share basis, as
--- ----
consideration in the Merger. Upon the surrender of certificates representing
their shares of common stock, no par value of Senesco ("Senesco Common") on the
effective date of the Merger (the "Effective Date"), Senesco's shareholders will
receive one share of Common Stock for each share of Senesco Common so
surrendered. Due to the Company's issuance of the Merger Shares, the Merger will
result in a 63% reduction in the ownership interests of the current shareholders
of the Company. Following consummation of the Merger, Senesco's shareholders
will collectively own a majority interest in the Company and Senesco's President
and principal shareholder, Mr. Phillippe Escaravage, will own an approximate
34.65% interest in the Company.
The Merger Shares are being issued pursuant to Sections 4(2) and 4(6) of
the Securities Act of 1933, as amended (the "Act'). The Merger Shares are being
offered exclusively to holders of Senesco Common on the Effective Date. As of
the date hereof, there are 13 shareholders of record owning shares of Senesco
Common. The Company has made available to Senesco's shareholders copies of this
Proxy Statement, the Company's Annual Report on Form 10-KSB for the fiscal year
ended June 30, 1998 and the Company's Quarterly Report on Form 10-QSB for the
quarter ended September 30, 1998. In addition, the Company has offered Senesco's
shareholders opportunity to ask questions of the Company's officers. There is
currently no public trading market for the Senesco Common.
JOINT REASONS FOR THE MERGER
8
Discussions between the Company and Senesco began in connection with
Senesco's attempts to secure financing to fund its research and development
efforts and the Company's desire to acquire a company with active operations
and/or a business plan currently in the process of being implemented. Since
there is no public trading market for Senesco's securities, Senesco's options
are currently limited to private sources of financing.
Indications pointing to the expectation that Senesco's technology can be
successfully developed into marketable products, together with the estimated
size of potential market for such products, prompted Senesco's management to
look towards a means of financing that would create more tangible value for
Senesco's shareholders in the near term than the taking of commercial loans,
which would burden Senesco with bank debt payment obligations and covenants
which could restrict Senesco's future, activities, or the securing of venture
capital financing, which would similarly result in ongoing dividend payment
obligations and would dilute Senesco's current outstanding ownership interests.
To that end, it was suggested by Senesco's business advisor that Senesco merge
with a public entity having an existing shareholder base and no current
operations, such as the Company. After being introduced to the Company by its
business advisor, Senesco began negotiations regarding a merger with the Company
and, on October 2, 1998, the two companies entered into a letter of intent
outlining the basic terms of the Merger, the Reorganization and the Reverse
Split. After further negotiations, on October 9, 1998, the Company and Senesco
entered into a definitive Merger Agreement, a copy of which is included in
Exhibit A to this Proxy Statement.
The Boards of Directors of the Company and Senesco believe that the Merger
will benefit both companies. The Company's and Senesco's Boards have each
identified a number of potential benefits of the Merger, including:
(1) Fulfilling the Company's business purpose of acquiring an operating
company or a company with a business plan in the process of being
implemented;
(2) Allowing Senesco to obtain a larger shareholder base and establish a
public trading market for its securities;
(3) Helping Senesco gain the interest of investment bankers and brokerage
firms that only raise capital for public companies; and
(4) Enabling Senesco to access public capital markets to raise money for
research and development efforts.
MATERIAL FEDERAL INCOME TAX CONSEQUENCES
The following discussion was prepared by Jones, Jensen & Company, LLC
accountants to the Company, and summarizes the material Federal income tax
consequences of the Merger to the Company's and Senesco's shareholders under the
Internal Revenue Code of 1986, as amended (the "Code"), but does not cover all
tax consequences of the Merger that may be relevant to the Company's and
Senesco's stockholders in light of their particular circumstances, such as the
tax
9
consequences to those of the Company's shareholders who do not hold their Common
Stock as a capital asset, foreign persons, insurance companies, tax-exempt
organizations, financial institutions, securities dealers, broker-dealers or
persons who acquired their shares in compensatory transactions. Furthermore, no
foreign, state or local tax considerations are addressed herein.
THIS SUMMARY SHOULD NOT BE REGARDED AS A SUBSTITUTE FOR AN INDIVIDUAL
ANALYSIS OF THE TAX CONSEQUENCES OF THE MERGER TO A SHAREHOLDER. EACH
SHAREHOLDER SHOULD CONSULT HIS OR HER OWN TAX ADVISOR REGARDING THE PARTICULAR
FEDERAL, STATE, LOCAL, FOREIGN AND OTHER TAX CONSEQUENCES OF THE MERGER TO SUCH
STOCKHOLDER'S OWN PARTICULAR SITUATION.
The Merger is expected to be treated a nontaxable reorganization within the
meaning of Section 368(a)(1)(a) of the Code.
Based upon the foregoing, the Merger will result in the following Federal
income tax consequences:
(a) no gain or loss will be recognized by holders of the Company's
Common Stock upon the exchange of the outstanding shares of
Senesco Common for the Merger Shares;
(b) no gain or loss will be recognized by Senesco's shareholders upon
the exchange of their shares of Senesco Common for shares of
Common Stock of the Company; and
(c) the holding period of Senesco's shareholders with respect to the
Merger Shares received by them in the Merger will not include the
holding period of such shareholders with respect to the shares of
Senesco Common surrendered in exchange therefor.
STATEMENT OF ACCOUNTING
The transaction will be accounted for as a reorganization of Senesco
because the shareholders of Senesco will own a controlling interest in the
Company after the Merger. Senesco will therefore be treated as the acquiring
entity for accounting purposes and, accordingly, there will be no adjustment to
the carrying value of the assets or liabilities of the Company, notwithstanding
that the Company is the acquiring entity for legal purposes.
Each Senesco shareholder should consult a tax advisor as to the particular
consequences of the Merger that may apply to such shareholder, including the
application of state, local, foreign and other Federal tax laws.
10
Shareholders owning an aggregate of 1,482,020 shares, representing 49.4%,
of the Company's outstanding Common Stock have indicated to the Company that
they will vote in favor of the Merger and related transactions. Such
shareholders are parties in their individual capacities as shareholders to the
Merger Agreement.
THE BOARD OF DIRECTORS HAS UNANIMOUSLY APPROVED THE MERGER AGREEMENT AND
THE TRANSACTIONS CONTEMPLATED THEREBY AND RECOMMENDS THAT SHAREHOLDERS VOTE
FOR PROPOSAL 1.
---
PROPOSAL 2
REVERSE STOCK SPLIT
As a condition to consummation of the Merger, immediately prior thereto the
Company will effect the Reverse Split with respect to the outstanding shares of
Common Stock. Pursuant to the Reverse Split, each three outstanding shares of
Common Stock will be automatically converted into one share of Common Stock. In
the event that as a result of the Reverse Split a shareholder would own a
fractional share, the Company will issue to such shareholder an additional full
share of Common Stock in lieu thereof. The Reverse Split will not change the
total number of authorized shares or the par value of the Common Stock. The
Company currently has 3,000,025 shares of Common Stock issued and outstanding.
After giving effect to the Reverse Split, the Company will have approximately
1,000,008 shares of Common Stock issued and outstanding. As a result of the
Reverse Split, the number of authorized shares of Common Stock available for
future issuance will increase from 46,999,975 to approximately 48,999,992.
REASONS FOR THE REVERSE SPLIT
The reasons for the Reverse Split are as follows:
(1) To increase the number of authorized shares available for future
issuance pursuant to (a) stock option and ownership plans and other
compensation arrangements with management, employees and outside
consultants; (b) capital-raising transactions, such as public
offerings and private placements of the Company's securities; and (c)
acquisitions of other businesses and technologies; and
(2) To reduce the size of the public float in order to discourage short
selling and encourage market makers to make a market in the Common
Stock.
Shareholders owning an aggregate of 1,482,020 shares, representing 49.4%,
of the Company's outstanding Common Stock have indicated to the Company that
they will vote in favor of the Reverse Split. Such shareholders are parties in
their individual capacities as shareholders to the Merger Agreement.
11
THE BOARD OF DIRECTORS HAS UNANIMOUSLY APPROVED THE REVERSE SPLIT AND
RECOMMENDS THAT SHAREHOLDERS VOTE FOR PROPOSAL 2.
---
PROPOSAL 3
AMENDMENT OF ARTICLES OF INCORPORATION
The Board of Directors has proposed that the Company amend its Articles of
Incorporation in order to change its corporate name to "Senesco Technologies,
Inc.". Management believes that the change of corporate name will better
reflect the business direction of the Company as it succeeds to the business of
Senesco.
Shareholders owning an aggregate of 1,482,020 shares, representing 49.4%,
of the Company's outstanding Common Stock have indicated to the Company that
they will vote in favor of the Amendment of the Company's Articles of
Incorporation. Such shareholders are parties in their individual capacities as
shareholders to the Merger Agreement.
THE BOARD OF DIRECTORS HAS UNANIMOUSLY APPROVED THE AMENDMENT OF THE
COMPANY'S ARTICLES OF INCORPORATION AND RECOMMENDS THAT SHAREHOLDERS VOTE
FOR THE PROPOSAL 3.
---
PROPOSAL 4
ELECTION OF DIRECTORS AND INCREASE IN
THE NUMBER OF MEMBERS OF THE BOARD OF DIRECTORS
In connection with the Merger, the number of members of the Board of
Directors will be increased from three persons to five persons. The current
directors of the Company have agreed to resign and the following three persons,
two of whom have been nominated by the current management of Senesco and one of
whom has been nominated by the Board of Directors of the Company, have been
nominated for election at the Special Meeting of Shareholders. Two of such
persons would serve as directors of the Company until the next Annual Meeting of
Shareholders or until their successors have been elected and qualified. Mr.
Katz, who was nominated for election by the Company's Board of Directors, would
hold office for a two-year term until the Year 2000 Annual Meeting of
Shareholders or until his successor is elected and qualified. See, "Proposal 5
- -Amendment of By-Laws." Such nominations were made pursuant to agreement by the
Company and Senesco in Section 1.3(iii) of the Merger Agreement. Although
management does not anticipate that any of the persons named below will be
unable or unwilling to stand for election, in the event of such an occurrence,
Proxies may be voted for a substitute nominee designated by the Board of
Directors. Since suitable candidates for nomination for election to the
remaining two vacancies have
12
not yet been identified and selected by management, such vacancies are
anticipated to be filled by the majority vote of the three directors elected at
the Special Meeting and of Shareholders. The two members so elected would hold
office until the next Annual Meeting of Shareholders or until their successors
are duly elected and qualified. Shareholders who wish to make their own
nominations for the Board of Directors may do so by indicating such on their
Proxies or by making an oral nomination at the Special Meeting of Shareholders.
A vote FOR each of the nominees for election to the Board of Directors will also
---
be a vote FOR increasing the number of members of the Board of Directors unless
---
indicated otherwise on a shareholder's Proxy.
NOMINEES FOR DIRECTOR
The nominees for Director and biographical information regarding each are
as follows:
CLASS OF OTHER OFFICES
NAME AGE DIRECTORS TO BE HELD
-------- --------- --------- -------------
Phillippe Escaravage 22 A President &
(1 year term) Treasurer
Christopher Forbes 47 A
(1 year term)
Steven Katz 50 B
(2 year term)
Phillippe Escaravage
- --------------------
Phillippe Escaravage is the founder of and was the President of Senesco,
LLC since June 1998; he is now President of Senesco. He is also the founder and
President of Escaravage Biological Industries, LLC (June 1997 to present).
Escaravage Biological Industries, LLC is engaged in the business of making
investments in early stage biotechnology products. Mr. Escaravage received a
Bachelor of Arts degree in economics from Princeton University in June, 1997.
Mr. Escaravage is the son-in-law of Christopher Forbes, a nominee for
Director.
Christopher Forbes
- ------------------
Christopher Forbes is Vice-Chairman of Forbes, Inc., which publishes
Forbes, the nation's leading business magazine. He is responsible for Forbes'
advertising and promotion departments. From 1981 to 1989, Mr. Forbes was
Corporate Secretary at Forbes. Prior to 1981, he held the position of Vice-
President and Associate Publisher. Mr. Forbes became a Forbes, Inc. Director in
1977.
Mr. Forbes sits on the boards of The New York Historical Society, The
Newark Museum, The Business Committee for the Arts, The Brooklyn Museum, The
Friends of New Jersey State Museum, the New York Academy of Art, The Victorian
Society in America, The Princess Margarita Foundation and The Prince Wales
Foundation. He is also a member of the Board of Advisors of The Princeton
University Art Museum, a National Trustee of the Baltimore Museum of Art, and
serves
13
on the Advisory Committee of the Department of European Decorative Arts of the
Museum of Fine Arts in Boston. In 1987, he was appointed to the Board of Regents
of the Cathedral of St. John The Divine in New York City.
Mr. Forbes received a Bachelor of Arts degree in Art History from Princeton
University in 1972. In 1986, he was awarded the honorary degree of Doctor of
Humane Letters by New Hampshire College.
Mr. Forbes is the father-in-law of Phillippe Escaravage, a nominee for
Director.
Steven Katz
- -----------
Steven Katz is President of Steven Katz & Associates, Inc., a management
consulting firm specializing in strategic planning, corporate development, new
product planning, technology licensing, and structuring and securing various
forms of financing. From 1983 to 1984, he was the co-founder and Executive Vice
President of S.K.Y. Polymers, Inc., a bio-materials company. Prior to this,
Mr. Katz was Vice President and General Manager of a non-banking division of
Citicorp, N.A. From 1976 to 1980, he held various senior management positions
at National Patent Development Corporation, including President of three
subsidiaries. Prior positions were with Revlon, Inc. (1975) and Price
Waterhouse & Co. (1969 to 1974). Mr. Katz received a Bachelor of Business
Administration degree in Accounting from the City College of New York in 1969.
He is presently a member of the board of directors of several other companies.
All of the above-named individuals have consented to being named in this
Proxy Statement and have indicated that they will serve on the Company's Board
of Directors if elected. The Company has agreed to obtain Directors' and
Officers' insurance on all post-Merger Directors and Officers.
SIGNIFICANT EMPLOYEES
In addition, following completion of the Merger the Company expects to have
the following significant employees:
SASCHA FEDYSZYN, 23, VICE-PRESIDENT.
Mr. Fedyszyn has been the Vice-President of Senesco since its formation in
November 1988. Mr. Fedyszyn had been the Executive Vice-President of Senesco,
LLC since June 1998. He is also Vice-President of Escaravage Biological
Industries, LLC (October 1997 to present). Mr Fedyszyn's prior work experience
was as Research Associate at the Logistics Management Institute (May 1995 -
September 1995). He also received a Bachelor of Arts degree from Princeton
University in Biology in June 1997.
CHRISTIAN AHRENS, 22, SECRETARY.
14
Mr. Ahrens has been the Secretary of the Company since its formation in
November 1998. Mr. Ahrens had been Vice-President of Operations for Senesco, LLC
since June 1998. Prior to joining Senesco, he attended Princeton University,
where he received a Bachelor of Arts degree in History in May 1998
The Company is presently negotiating three-year employments agreement with
Mr. Escaravage and each of the two above-named individuals.
Shareholders owning an aggregate of 1,482,020 shares, representing 49.4%,
of the Company's outstanding Common Stock have indicated to the Company that
they will vote in favor of increasing the number of members of the Board of
Directors from three (3) persons to five (5) persons and in favor of the
election of each of the above-named nominees to the Board of Directors. Such
shareholders are parties in their individual capacities as shareholders to the
Merger Agreement.
THE BOARD OF DIRECTORS HAS UNANIMOUSLY APPROVED, AND RECOMMENDS, THAT
SHAREHOLDERS VOTE FOR INCREASING THE NUMBER OF MEMBERS CONSTITUTING THE
---
BOARD OF DIRECTORS AND FOR THE ELECTION TO THE BOARD OF DIRECTORS OF EACH
---
OF THE PERSONS NAMED ABOVE AS A NOMINEE.
PROPOSAL 5
AMENDMENT OF BY-LAWS
The Board of Directors has proposed that, in connection with the Merger,
the Company's By-laws be amended to create two classes of directors of the
Company: (1) Class A, consisting of four directors who would be elected to a
one-year term; and (ii) Class B, consisting of one director who would be elected
to a two-year term.
Vacancies occurring with respect to any directorship would be filled by
appointment by the remaining directors. In such event, any Class A Directors so
appointed would hold office until the next Annual Meeting of Shareholders and a
Class B Director so appointed would hold office for the remainder of the full,
two-year term.
The purpose of the amendment to the Company's By-laws is to ensure
continuity of management of the Company by providing the current shareholders of
the Company representation by at least one member of the Board for a two-year
period following the Merger.
Shareholders owning an aggregate of 1,482,020 shares, representing 49.4%,
of the outstanding Common Stock have indicated to the Company that they will
vote in favor of amending the Company's By-laws. Such shareholders are parties
in their individual capacities as shareholders to the Merger Agreement.
15
THE BOARD OF DIRECTORS HAS UNANIMOUSLY APPROVED THE AMENDMENT TO THE
COMPANY'S BY-LAWS AND RECOMMENDS THAT SHAREHOLDERS VOTE FOR PROPOSAL
---
5.
PROPOSAL 6
REINCORPORATION IN STATE OF DELAWARE
The Board of Directors has proposed that, as soon as practicable after
completion of the Merger, the Company change its state of incorporation from
Idaho to Delaware by share purchase and exchange or by merging at a later date
into a new corporation which would be formed in Delaware to facilitate the
reincorporation and would be capitalized identically to the Company. Management
believes that the change in the Company's state of incorporation will better
suit the corporate agenda and business direction of the Company; however, if
such action will in any way adversely affect the Company's status as a public
company, as determined by the Company's legal counsel, then such action will not
be taken and the shareholders will be informed.
Shareholders owning an aggregate of 1,482,020 shares, representing 49.4%,
of the outstanding Common Stock have indicated to the Company that they will
vote in favor of the reincorporation in the State of Delaware. Such
shareholders are parties in their individual capacities as shareholders to the
Merger Agreement.
THE BOARD OF DIRECTORS HAS UNANIMOUSLY APPROVED THE REINCORPORATION AND
RECOMMENDS THAT SHAREHOLDERS VOTE FOR PROPOSAL 6 SUBJECT TO THE ADVICE OF
---
COUNSEL.
PROPOSAL 7
THE BRIDGE LOAN
Senesco's Business Plan contemplates obtaining additional financing
following completion of the Merger by means of one or more private placements
or public offerings (each, an "Offering") of newly-issued equity or convertible
debt securities of the Company; however, neither Senesco nor the Company
currently has any formal agreement, arrangement or understanding with any third
party regarding any such Offering and there can be no assurance that any such
Offering will, in fact, occur or be consummated.
In order to cover expenses associated with the Merger and fund the ongoing
operations of Senesco's business in the interim, on October 22, 1998 Senesco
entered into a Loan Agreement with South Edge International Limited, providing
for up to $500,000 in financing (the "Bridge Loan"). The Bridge Loan is
evidenced by a Promissory Note bearing interest at an annual rate equal to the
prime rate plus 2% and will become due and payable in full on the date of the
earlier to occur of:
16
(1) such date (if any), following completion of the Merger, on which Senesco
shall consummate an offering and sale of equity or convertible debt securities
which yields more than $500,000 in gross proceeds; and (2) October 22, 1999.
Upon consummation of the Merger, the Note will become a liability of the
Company. To date, Senesco has drawn down approximately $164,000 under the Bridge
Loan. Following consummation of the Merger, the Company anticipates drawing down
all of the remaining funds available under the Bridge Loan on a monthly
basis.
Shareholders owning an aggregate of 1,482,020 shares, representing 49.4%,
of the outstanding Common Stock have indicated to the Company that they will
vote in favor the Bridge Loan. Such shareholders are parties in their
individual capacities as shareholders to the Merger Agreement.
THE BOARD OF DIRECTORS HAS UNANIMOUSLY APPROVED THE BRIDGE LOAN AND
RECOMMENDS THAT SHAREHOLDERS VOTE FOR PROPOSAL 7.
---
PROPOSAL 8
APPROVAL AND ADOPTION
OF THE STOCK OPTION PLAN
APPROVAL AND ADOPTION OF THE STOCK OPTION PLAN
The Board of Directors of the Company believes it is in the best interests
of the Company to encourage stock ownership by its employees. Accordingly, the
Board of Directors approved the establishment of the 1998 Stock Option Plan (the
"Stock Option Plan") on November _____, 1998, subject to approval of the
shareholders of the Company. Options to purchase an aggregate of 500,000 post-
Reverse Split shares of Common Stock (subject to adjustment for any stock
dividend, stock split or other relevant changes in the Company's capitalization)
may be sold pursuant to the Stock Option Plan. The text of the Stock Option
Plan is attached as Exhibit B to this Proxy Statement. Set forth below is a
summary of the material provisions of the Stock Option Plan.
Under the Stock Option Plan, the Board of Directors may authorize the
issuance of options or stock purchase rights to purchase Common Stock to
designated employees and/or Directors of, and consultants to the Company. All
employees of the Company will be eligible to participate in the Stock Option
Plan. The reasons for adopting the Stock Option Plan are: (1) to enable the
Company to attract and retain the best available personnel for positions of
substantial responsibility; (2) to provide additional incentive to employees,
Directors and consultants of the Company and Senesco; (3) and to promote the
success of the Company's business.
The material features of the Stock Option Plan are as follows:
17
Under the Stock Option Plan, the Board of Directors may, in its discretion,
award either incentive stock options ("ISOs") or nonstatutory stock options
("NSOs"). Grants of ISOs may be made only to employees of the Company, while
NSOs may be granted to both employees and to non-employee directors and outside
consultants. To the extent that the fair market value of shares of Common Stock
subject to ISOs which become exercisable by any employee during any calendar
year exceeds $100,000, options for those shares representing the excess over
$100,000 will be treated as NSOs.
The per share exercise price for shares to be issued pursuant to exercise
of an option shall be determined by the Board of Directors subject to the
following guidelines:
(1) In the case of an ISO:
(a) granted to an employee who, at the time of the grant of such
ISO, owns shares representing more than 10% of the aggregate voting
power of all classes of capital stock of the Company, the per share
exercise price shall be no less than 110% of the fair market value of
a share of Common Stock on the date of grant; or
(b) granted to any other employee, the per share exercise price
shall be no less than 100% of the fair market value of a share of
Common Stock on the date of such grant.
(2) In the case of a NSO:
(a) granted to a person who, at the time of the grant of such
NSO, owns stock shares representing more than 10% of the aggregate
voting power of all classes of capital stock of the Company, the per
share exercise price shall be no less than 110% of the fair market
value of a share of Common Stock on the date of grant; or
(b) granted to any other person, the per share exercise price
shall be no less than 85% of the fair market value on the date of such
grant.
(3) Stock Purchase Rights, if authorized and implemented pursuant to
a Restricted Stock Purchase Agreement approved by the Board of Directors,
may be issued either alone or in conjunction with other plans adopted under
the Stock Option Plan. The Company's Board of Directors shall advise each
offeree of Stock Purchase Rights in writing of the terms, conditions and
restrictions related to the offer, including the number of shares the
offeree is entitled to purchase, the price to be paid (which price shall
not be less than 50% of the fair market value of the shares as of the date
of the offer), and the time within which such person must accept the offer,
which shall not exceed 30 days from the date upon which the determination
was made to grant the Stock Purchase Right.
18
In the event of an option holder's termination as an employee, officer or
director of, or consultant to, the Company or its subsidiaries, such holder may
exercise his or her options to the extent such options were vested on the date
of termination, but in the case of an ISO only within 90 days (or such other
period of time as is determined by the Board of Directors at the time of grant
of such ISO, with such determination being made at the time of grant of the
option and not exceeding 90 days) after the date of termination (but in no event
later than the termination date set forth in the option agreement governing the
option).
The term of options granted under the Stock Option Plan will be determined
by the Board of Directors of the Company; provided that (1) ISOs shall have a
maximum term of 10 years, and (2) options granted to persons owning more than
10% of the outstanding Common Stock will have a maximum term of five years.
The consideration to be paid for the shares to be issued upon exercise of
an option, including the method of payment, shall be determined by the
Administrator of the Stock Option Plan (the "Administrator") (and, in the case
of an ISO, shall be determined at the time of grant) and may consist entirely of
(1) cash, (2) check, (3) promissory note, (4) other shares which (x) in the case
of shares acquired upon the exercise of an option either have been owned by the
optionee for more than six months on the date of surrender or were not acquired,
directly or indirectly, from the Company, and (y) have a fair market value on
the date of surrender equal to the aggregate exercise price of the shares as to
which such option can be exercised, (5) authorization from the Company to retain
from the total number of shares as to which the option is exercised that number
of shares having a fair market value on the date of exercise equal to the total
exercise price for the number of shares as to which the option is exercised, (6)
delivery of a properly executed exercise notice together with irrevocable
instructions to the option holder's broker to promptly deliver to the Company
the amount of sale or loan proceeds required to pay the exercise price, (7) by
delivering an irrevocable subscription agreement for the shares, which
irrevocably obligates the option holder to take and pay for the shares not more
than 12 months after the date of delivery of the subscription agreement, (8) any
combination of the foregoing methods of payment, or (9) such other consideration
and method of payment for the issuance of shares to the extent permitted under
applicable laws. In making its determination as to the type of consideration to
accept, the Administrator shall consider whether acceptance of such
consideration may be reasonably expected to benefit the Company.
Any option granted hereunder shall be exercisable at such times and under
such conditions as determined by the Administrator, including performance
criteria with respect to the Company and/or optionee, and as shall be
permissible under the terms of the Stock Option Plan.
An option may not be exercised for a fraction of share.
An option shall be deemed to be exercised when written notice of such
exercise has been given to the Company in accordance with the terms of the
option by the person entitled to exercise the option and full payment for the
shares with respect to which the option is exercised has been received by the
Company. Until the issuance (as evidenced by the appropriate entry on the
books
19
of the Company or of a duly authorized transfer agent of the Company) of the
stock certificate evidencing such shares, no right to vote or receive dividends
or any other rights as shareholder shall exist with respect to the option
shares, notwithstanding the exercise of the option. The Company shall issue (or
cause to be issued) such certificate promptly upon the exercise of the
option.
Exercise of an option in any manner shall result in a decrease in the
number of shares which thereafter may be available, both for purposes of the
Stock Option Plan and for sale under the option, by the number of shares as to
which the option is exercised.
The Company currently does not have any stock option plans under which
officers, Directors or employees of the Company may participate.
ADMINISTRATION AND ELIGIBILITY
The Stock Option Plan will be administered by the Administrator or by a
committee appointed by the Company's Board of Directors (the "Committee"). The
Committee has the authority to interpret all provisions of the Stock Option
Plan. All employees of the Company and its participating subsidiaries who have
been employed by the Company or Senesco for at least one year are eligible to
participate in the Stock Option Plan, except for employees whose customary
employment is 20 hours or fewer per week or employees whose customary employment
is for not more than five months in any calendar year. Upon consummation of the
Merger, approximately three employees will be eligible to participate in the
Stock Option Plan.
In addition, nonemployee Directors and outside consultants to the Company
will be eligible for grants of NSOs under the Stock Option Plan.
AMENDMENT AND TERMINATION
The Board of Directors of the Company may amend the Stock Option Plan at
any time; however, the Stock Option Plan may not be amended in any way that will
cause rights issued thereunder to fail to meet the requirements for employee
stock option plans as defined in Section 423 of the Code, including stockholder
approval if required.
The Stock Option Plan shall terminate upon the earliest to occur of: (1)
such date on which options to purchase an aggregate number of shares of Common
Stock equal to or greater than the number of shares reserved under the Stock
Option Plan have been granted, or (2) the date on which the Stock Option Plan is
terminated by the Board of Directors; or (3) November _____, 2008.
INTERESTS OF CERTAIN PERSONS IN THE TRANSACTIONS
No officer or director of the Company serves as an officer or director of
Senesco or owns any shares of Senesco Common or other ownership interests in
Senesco. None of the officers, directors
20
or principal shareholders of the Company has any substantial interest in the
proposals discussed herein to be voted upon at the Special Meeting of
Shareholders.
Shareholders owning an aggregate of 1,482,020 shares, representing 49.4%,
of the outstanding Common Stock have indicated to the Company that they will
vote in favor of the approval and adoption the Stock Option Plan.
THE BOARD OF DIRECTORS HAS UNANIMOUSLY APPROVED THE STOCK OPTION PLAN AND
RECOMMENDS THAT SHAREHOLDERS VOTE FOR PROPOSAL 8.
---
PROPOSAL 9
APPOINTMENT OF AUDITORS
Jones, Jensen & Company, LLC served as the principal accountants to the
Company for the fiscal year ended June 30, 1998.
The Board of Directors has arranged for Goldstein Golub Kessler & Co., P.C.
to be its auditors for the fiscal year ending June 30, 1999 subject to the
consummation of the Merger and approval by the Company's shareholders. The
Company expects a representative of each of Jones, Jensen & Company, LLC and
Goldstein Golub Kessler & Co., P.C. to attend the Special Meeting and be
available for questions.
Shareholders owning an aggregate of 1,482,020 shares, representing 49.4%,
of the outstanding Common Stock have indicated to the Company that they will
vote in favor of the appointment of Goldstein Golub Kessler & Co., P.C., as the
Company's auditors or the fiscal year ending June 30, 1999.
THE BOARD OF DIRECTORS HAS UNANIMOUSLY APPROVED THE APPOINTMENT OF
GOLDSTEIN GOLUB KESSLER & CO., LLC AS THE COMPANY'S AUDITORS FOR THE FISCAL
YEAR ENDING JUNE 30, 1999 AND RECOMMENDS THAT STOCKHOLDERS VOTE FOR
---
PROPOSAL 9.
DISSENTERS' RIGHTS
Idaho law provides that shareholders entitled to vote on the Merger have a
right to elect to dissent to the Merger and obtain payment for their shares of
Common Stock. Shareholders wishing to exercise their rights to dissent to the
Merger and demand payment for their shares must give written notice of such
intention to the Company prior to the time when the vote on Proposal 1 is taken
at the Special meeting of shareholders.
21
The following summary of ID Statute Sections 30-1-1302 to 30-1-1331 is NOT
intended to be a complete statement of the provisions of such sections and is
qualified in its entirety by the referenced Exhibit C annexed hereto.
ANY SHAREHOLDER WHO WISHES TO DISSENT AND OBTAIN PAYMENT FOR HIS OR HER SHARES
MUST VOTE SUCH SHARES AGAINST, OR ABSTAIN FROM VOTING FOR, THE MERGER.
In the case of shareholders of record who do not have beneficial ownership
of all shares held of record, a demand for payment may be made with respect to
fewer than all shares held of record, provided that such demand is made with
respect to all shares beneficially owned by any one person or over which any one
person has sole voting power.
In the event that the Company receives written notice of an intent to
demand payment from any shareholder prior to the time that the vote on Proposal
1 is taken at the Special Meeting of Shareholders, then within 10 days following
the Special Meeting of Shareholders the Company will send to such shareholder a
form for demanding payment accompanied by a copy of Chapter 13 of the Idaho
General Business Corporation Law, which governs dissenter's rights, and written
notice to such shareholder specifying: (1) where such shareholder must send a
demand for payment and where and when the certificates for certificated shares
must be deposited; (2) in the case of a holder of uncertificated shares, to what
extent transfer of shares of such shares will be restricted after its demand for
payment is received; and (3) the date by which the Company must receive a
completed and executed payment demand from such shareholder, such date to be
between 30 and 60 days following the date on which the Company delivered the
form of payment demand to such shareholder.
The form of payment demand shall specify the date on which the Company
first announced the proposed Merger to its shareholders or to the news media
and will require a shareholder making a demand for payment to certify that it
acquired beneficial ownership of its shares prior to such date. A shareholder
making a demand for payment with respect to shares acquired after the date on
which the terms of Merger were first announced to the Company's shareholders or
to the news media ("After-Acquired Shares") will receive payment of the fair
value of such shares plus accrued interest upon their agreeing in writing to
accept such payment in full satisfaction of such shareholder's demand with
respect to such shares. Such shareholder must then complete, execute and
return the form of payment and deposit its share certificates in accordance
with the terms specified in the payment form accompanying the notice.
Upon receipt of a payment demand, the Company shall pay the dissenting
shareholder from whom such demand was received the "fair value" of such
shareholder's shares, as determined in good faith by the Board of Directors of
the Company, plus accrued interest from the date of receipt of such demand.
Each such payment shall be accompanied by: (1) a statement of how the Company
arrived at its estimate of the fair value of the shares and how the interest on
such fair value was calculated; (2) a copy of the Company's Balance Sheet,
Income Statement and Statement of Changes
22
in Shareholders' equity at June 30, 1998 (the end of the Company's most recent
full fiscal year); (3) a copy of the Consolidated Pro Forma Financial Statements
of the Company at September 30, 1998; and (4) a copy of Chapter 13 of the Idaho
General Business Corporation Law.
In the event that the Merger is not consummated within 60 days after the
date set for payment, the Company will return all share certificates deposited
by, and release the transfer restrictions on all uncertificated shares of,
dissenting shareholders.
Any shareholder who disagrees with the Company's estimate of the fair value
of the shares, or who does not receive either payment of such fair value or
return of its share certificates within 60 days following the date set for
receipt by the Company of a demand for payment may so notify the Company in
writing within 30 days following the date on which the Company made or offered
to make payment or within 30 days following the date on which such payment
should have been made. In such event, the shareholder may specify its own
estimate of the fair value of its shares and amount of interest due and demand
payment of such amount. The Company will then have 60 days to either pay the
amount so specified or commence an action in the Idaho District Court for Summit
County petitioning the Court to determine the fair value of the shares. All
shareholders whose claims for payment remain unsettled will be made parties to
such action. Each shareholder will be entitled to judgement, (1) for the
amount, if any, by which the Court finds the fair value of such shareholders'
shares, plus interest, exceeds the amount paid by the Company, or (2) for the
fair value, plus accrued interest, of such shareholders' After-Acquired Shares
for which the Company elected to withhold payment. The Court will have power to
determine all costs of such proceeding and assess such costs against the
Company, provided that if the Court determines any dissenting shareholder has
not acted in good faith or has acted arbitrarily or vexatiously then the Court
may assess a portion of such costs against such shareholder as it may deem
equitable.
A copy of Chapter 13 of the Idaho General Business Corporation Law is
annexed as Exhibit C to this Proxy Statement.
The dissenters' rights detailed in ID Statute Section 30-1-1302 to 30-1-
1331, inclusive, are the sole rights of dissenting shareholders.
The Board of Directors of the Company believes that, as the Company
currently has no operations or assets, and the financing transactions described
in this Proxy Statement are all conditioned upon the consummation of the Merger
and the acquisition of the business of Senesco, that the value of any
dissenters' rights will be minimal.
RECORD DATE AND SHARE OWNERSHIP BY
PRINCIPAL SHAREHOLDERS AND MANAGEMENT
Only shareholders as of record of the close of business on November _____
1998 (the "Record Date"), are entitled to receive notice of and to vote at the
Special Meeting of Stockholders. As of the Record Date, the Company had
outstanding 3,000,025 shares of Common Stock.
23
The following table sets forth information, to the best knowledge of the
Company as of September 18, 1998, with respect to each person known by the
Company to own beneficially more than five percent of the Company's outstanding
Common Stock, each director of the Company and all directors and officers of the
Company as a group:
BEFORE THE MERGER AFTER THE MERGER
----------------- ----------------
NAME AND ADDRESS AMOUNT AND NATURE PERCENT AMOUNT AND NATURE PERCENT
BENEFICIAL OWNER OF BENEFICIAL OF OF BENEFICIAL OF
- ----------------
OWNERSHIP/1/ CLASS/2/ OWNERSHIP CLASS/3/
----------------- --------- ----------------- ---------
Edward F. Cowle 682,680 22.8% 227,560 8.43%
201 E. 87th St., Ste. 6C
New York, NY 10128 Direct Direct
David Williams 418,608 13.95% 139,536 5.16%
62 West 400 South
Salt Lake City, UT 84101 Direct Direct
H. D. Williams 372,096 12.4% 124,032 4.59%
62 West 400 South
Salt Lake City, UT 84101 Direct Direct
Mark W. McWhirter 198,452 6.61% 66,151 2.45%
3629 Steven White Dr.
San Pedro, CA 90731 Direct Direct
Dr. M. R. Moeen-Zaia 198,450 6.61% 66,150 2.45%
5024 Abuela Dr.
San Diego, CA 92124 Direct Direct
Jim Ruzicka/4/ 174,404 5.8% 58,135 2.15%
P. O. Box 3813
Park City, UT 84060 Direct Direct
- ---------------------------
/1/ Each person has sole voting, investment and dispositive power over the
shares opposite his name.
/2/ Based on 3,000,025 shares of Common Stock issued and outstanding on
October 8, 1998.
/3/ Based on approximately 2,700,008 shares of Common Stock issued and
outstanding after consummation of the Merger and the after the Reverse
Split.
/4/ Indicates a current Officer and Director
24
Sarasanan Blaendra 173,646 5.78% 57,882 2.14%
439 West 233rd St.
Carson, CA 90745 Direct Direct
J. Rockwell Smith/4/ 8,636 0.287% 2,879 0.206%
P. O. Box 3303
Park City, UT 84060 Direct Direct
James Kerr/4/ -0- -0- -0- -0-
4087 South 1300 E.
Salt Lake City, UT 84124 Direct Direct
Phillippe Escaravage/5/ /6/ -0- -0- 933,476 34.57%
11 Chambers Street
Princeton, NJ 08542 Direct Direct
Christopher Forbes/5/ -0- -0- 4,131 0.15%
Forbes, Inc.
50 5th Avenue
New York, NY 10011 Direct Direct
Steven Katz/5/ -0- -0- 24,820 0.92%
Steven Katz & Associates
Briar Ridge Plaza
440 Main Street Direct Direct
Milltown, NJ 08850
Sascha Fedyszyn/6/ -0- -0- 18,680 0.6.91%
11 Chambers Street
Princeton, NJ 08542 Direct Direct
Christian Ahrens/6/ -0- -0- 8,262 0.31%
11 Chamber Street
Princeton, NJ 08542 Direct Direct
John Thompson -0- -0- 425,000 15.74%
- ----------------------------
/5/ Indicates a nominee for Director
/6/ Indicates a proposed Officer
25
Office of the Dean
Faculty of Science Direct Direct
University of Waterloo
Waterloo, Ontario
Canada N2L 3G1
- --------------------------------------------------------------------------------
All Current Directors and
Executive Officers as a
Group (3 Persons) 183,040 6.10% 61,014 2.26%
All Nominees for Directors
and Proposed Officers as
a Group (5 Persons) -0- -0- 989,369 36.64%
To the knowledge of the Company's management, during the past five
years, no present or former director or executive officer of the Company:
(1) has been subject to a personal bankruptcy proceeding or has been a
general partner in a partnership or an executive officer of a corporation
that was subject to a bankruptcy proceeding within the past two years, (2)
has been convicted of a crime (other than a traffic violation or minor
court offense); (3) was the subject of a standing court order, judgment or
decree which permanently or temporarily enjoined him from engaging in any
type of business activity or barred, suspended or limited for more than 60
days his right to engage in any type of business activity relating to
investments, including: (a) acting as a merchant, broker, commodity trading
advisor or pool operator, investment advisor, underwriter or dealer in
securities, or as an affiliated person, director or employee of any
investment company; or (b) engaging in any activity in connection with the
purchase or sale of any security or commodity; or (4) was found by a court
of competent jurisdiction or by the Securities and Exchange Commission to
have violated any Federal or state securities law.
DESCRIPTION OF BUSINESS
HISTORY AND ORGANIZATION
- ------------------------
The Company was organized on April 1, 1964 under the laws of the State of
Idaho as Felton Products, Inc., having the stated purpose of engaging in various
investment activities, without limitation of its general corporate powers to
engage in any lawful activities. The Company engaged in limited investment and
business development operations and, from the time of its inception, the Company
has undergone several name and business changes.
26
On September 1, 1987, the Company changed its name to "Ink & Imagers, Inc."
There is no record of any business operations during the period the Company was
known as "Ink & Imagers, Inc." On November 16, 1988, the Company's name was
changed to "Nava Leisure USA, Inc." in anticipation of the acquisition of an
operating business incorporated in Delaware with the same name, Nava Leisure
USA, Inc., a Delaware corporation (hereinafter, "Nava (Delaware)"). The
acquisition and related stock exchange agreement was never completed, and all
rights and equity interest in the Company and Nava (Delaware) were transferred
to the Company by an Order Pursuant to Stipulation of the District Court for
Idaho, Sixth Judicial District, on December 11, 1995 (the "Order").
The acquisition agreement was rescinded and voided by the Order, which
canceled and made null and void any exchanges of stock related thereto. All
certificates related thereto were subsequently returned to the Company. On
December 16, 1995, a special meeting of the Board of Directors was held for the
purpose of canceling all shares of Common Stock and Preferred Stock issued by
the Company pursuant to the rescinded Nava (Delaware) transaction. The Order
and ensuing Board action terminated all further issues in dispute regarding the
litigation over the Nava (Delaware) transaction. A monetary judgment in the
amount of $40,440.04 associated with that proceeding in favor of the Company is
considered uncollectible and is therefore reflected as "0" in the Company's
financial statements for the fiscal year ended June 30, 1998, and is not a
material asset to the Company. Other than the rescinded acquisition transaction
and related litigation regarding Nava (Delaware), the Company has remained
inactive since before 1988, until now.
The present promoters of the Company obtained control between 1987 and 1988
by acquiring then-controlling shareholders' interests in the then-defunct and
inactive Felton Products, Inc., for purposes of the business acquisition which
failed in 1988. The promoters of the Company are its President, J. Rockwell
Smith, and three major shareholders: Edward F. Cowle; H.D. Williams; and David
Williams. On November 1, 1996, the Directors determined that the Company should
become active in seeking potential operating businesses and business
opportunities with the intent to acquire or merge with such businesses. The
Company then began to consider and investigate potential business opportunities.
The Company is considered a development stage company and, due to its status as
a "shell" corporation, its principal business purpose is to merge with or
otherwise acquire an operating entity.
The Company voluntarily filed a registration statement on Form 10-SB on
March 27, 1997 (as amended on July 10, 1997) in order to make information
concerning itself more readily available to the public. As a result of filing
its registration statement, the Company is obligated pursuant to the Securities
Exchange Act of 1934 (the "Exchange Act") to file with the Securities and
Exchange Commission certain interim and periodic reports, including an annual
report containing audited financial statements. The Company intends to continue
to voluntarily file these reports under the Exchange Act even if its obligation
to file such reports is suspended under applicable provisions of the Exchange
Act.
27
DESCRIPTION OF PROPERTIES
The Company's administrative offices are located at 253 Ontario No. 1, P.O.
Box 3303, Park City, Utah, 84060, which are the offices of its President, Mr. J.
Rockwell Smith. Acquisition Corp.'s administrative offices are also located at
the offices of Mr. Smith. Mr. Smith allows the Company to use these facilities
without charge. The Company does not own or control any material
properties.
The Company formed Acquisition Corp. in New Jersey on October 9, 1998.
Acquisition Corp. was formed as a wholly-owned subsidiary of the Company for the
sole purpose of effecting the acquisition of Senesco. Acquisition Corp. has no
assets or liabilities, and has never engaged in any business.
LEGAL PROCEEDINGS
No legal proceedings are pending at this time against the Company.
There are no material proceedings to which any director, officer or
affiliate of the Company, or any owner, beneficially or of record, of more than
five percent (5%) of the Company's outstanding Common Stock, is a party adverse
to the Company or has a material interest adverse to the Company.
SUBMISSION OF MATTERS TO A VOTE OF SECURITIES HOLDERS
No matters were submitted to a vote of shareholders of the Company during
the fiscal year ended June 30, 1998, nor since that time until the date of this
Proxy Statement.
MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
The Company is not aware of any reported quotations for its Common Stock,
now or at any time within the past nine years. The Company's shares are
eligible to be quoted on the Nasdaq OTC Bulletin Board under the symbol "NAVL".
Inclusion on the OTC Bulletin Board permits price quotations for the Company's
shares to be published by such service. The Company is not aware of any
established trading market for its Common Stock nor is there any record of any
reported trades in the public market in recent years. The Company's Common
Stock has not traded in a public market since 1988. Since its inception, the
Company has not paid any dividends on its Common Stock, and the Company does not
anticipate that it will pay dividends in the foreseeable future. At October 8,
1998, the Company had 387 shareholders.
MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
The Company has been considered a development stage company with no assets
or capital and with no operations or income since approximately 1988. In their
report on the Audited Financial Statements of the Company for the fiscal year
ended June 30, 1998, Jones, Jensen & Company, LLC, auditors for the Company
expressed substantial doubt as to the Company's ability to continue as a going
concern. The costs and expenses associated with the preparation and filing of
this Proxy Statement and other operations of the Company have been paid for by
its shareholders, specifically
28
H.D. Williams. It is anticipated that until completion of the Merger, the
Company will require only nominal capital to maintain its corporate viability
and necessary funds will most likely be provided by the Company's existing
shareholders or its officers and directors in the immediate future. Following
completion of the Merger, the Company anticipates raising additional funds by
drawing down the remainder of the funds available under the Bridge Loan and/or
through an Offering. See, "Proposal 7 -the Bridge Loan".
In the opinion of management, inflation has not and will not have a
material effect on the operations of the Company until such time as the Company
has successfully completed the Merger.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
DISCLOSURE
The reports of the Company's principal accountants on the Company's
financial statements for the past two fiscal years did not contain any adverse
opinion or disclaimer of opinion, nor was any such report modified as to
uncertainty, audit scope or accounting principles.
During the fiscal year ended June 30, 1998, the Company had no
disagreements with its certified public accountants with respect to accounting
practices or procedures or financial statement disclosure or auditing scope or
procedure which, if not resolved to such accountants' satisfaction, would have
caused them to make reference to the subject matter of such disagreement in
their report.
Following the Merger, the Company will engage Goldstein Golub & Kessler as
its auditors (See "Proposal 9 -- Appointment of Auditors").
BOARD MEETINGS AND COMMITTEES
The Board of Directors of the Company held no meetings during the fiscal
year ended June 30, 1998.
The Board of Directors does not have an audit, compensation or nominating
committee or any other committee.
EXECUTIVE OFFICERS
Capacities in In Current
Name Age Which Served Position Since
---- --- ------------ --------------
J. Rockwell Smith 59 President and Director 1987
Jim Ruzicka 55 Vice President and Director 1998
James Kerr 43 Secretary, Treasurer and 1995
Director
29
Set forth below is certain biographical information regarding the Company's
executive officers and directors.
J. Rockwell Smith has been President and a Director of the Company since
1987. From 1977 to 1989, Mr. Smith owned and operated his own construction
company in Park City, Utah, named Rocky Smith Construction, which supervised
construction projects in this resort community. From 1990 to the present, Mr.
Smith has been employed as a driver by the Park City Transportation Company.
Mr. Smith studied engineering at Seattle University and the University of
Washington.
Jim Ruzicka is the Vice-President of the Company, and has been a Director
of the Company since August 15, 1998. For the last five years (and previously),
Mr. Ruzicka has been the owner-operator of a ski tour package company doing
business in Utah, Colorado, Wyoming, and California. Prior to 1983, he owned and
operated seven restaurants in Chicago, Illinois and surrounding suburbs. He
attended Aurora College in Aurora, Illinois, studying liberal arts without
receiving a degree.
James Kerr has been Secretary-Treasurer and a Director of the Company since
1995. Since 1994, Mr. Kerr has worked as an independent production manager
and/or lighting technician for a number of companies situated in and around Salt
Lake City, Utah, including Great Day Ltd., Video West, Bonneville
Communications, Scopes, Garcia & Carlisle, Rutherford Productions, Stillson &
Stillson and Advantage Video. In 1993, Mr. Kerr was employed in equipment
repair and maintenance for Redman Movies & Stories of Salt Lake City, Utah, and
as a ski test programmer for Great Day Ltd. Of Utah. Previously, he has
operated his own business as a self-employed independent auto mechanic.
EXECUTIVE COMPENSATION
SUMMARY
The Company has not had a bonus, profit sharing, or deferred compensation
plan for the benefit of its employees, officers or directors. The Company has
not paid any salaries or other compensation to its officers, directors or
employees for the years ended June 30, 1997 and 1998, nor at any time during
calendar year 1998. Although the Company has not entered into an employment
agreement with any of its officers, Directors or any other persons, it
anticipates entering into three-year employment agreements with Messrs.
Escaravage, Fedyszyn and Ahrens. See, "Proposal 4 -- Election of Directors --
Significant Employees." As of the date hereof, no person has accrued any
compensation from the Company.
COMPENSATION
No form of compensation was paid to any officer or Director at any time
during the last three fiscal years.
30
CASH COMPENSATION
There was no cash compensation paid to any Director or executive officer of
the Company during the fiscal years ended June 30, 1998, 1997, or 1996.
BONUSES AND DEFERRED COMPENSATION
There were no bonuses paid to any Director or executive officer of the
Company during the fiscal years ended June 30, 1998, 1997 or 1996, nor was there
any deferred compensation.
COMPENSATION PURSUANT TO PLANS
There was no compensation pursuant to any plan paid to any Director or
executive officer of the Company during the fiscal years ended June 30, 1998,
1997 or 1996.
OTHER COMPENSATION
There was no other compensation paid to any Director or executive officer
of the Company during the fiscal years ended June 30, 1998, 1997 or 1996.
COMPENSATION OF DIRECTORS
There was no compensation paid to any Director of the Company during the
fiscal years ended June 30, 1998, 1997 or 1996.
TERMINATION OF EMPLOYMENT AND CHANGE OF CONTROL ARRANGEMENT:
There are no compensatory plans or arrangements of any kind, including
payments to be received from the Company, with respect to any person which would
in any way result in payments to any such person because of his or her
resignation, retirement, or other termination of such person's employment with
the Company or its subsidiaries, or any change in control of the Company, or a
change in the person's responsibilities following a change in control of the
Company.
COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT
The Company's Common Stock is registered pursuant to Section 12(g) of the
Exchange Act and, in connection therewith, Directors, officers, and beneficial
owners of more than 10% of the Company's Common Stock are required to file on a
timely basis certain reports under Section 16 of the Exchange Act as to their
beneficial ownership of the Company's Common Stock. The following table sets
forth, as of the date of this Proxy Statement, the name and relationship of each
person who failed to file on a timely basis any reports required pursuant to
Section 16 of the Exchange Act:
31
NUMBER
NAME POSITION REPORT TO BE FILED OF REPORTS
---- -------- ------------------ ----------
J. Rockwell Smith President and Director Form 3 1
Jim Ruzicka Vice President and Director Form 3 1
James Kerr Secretary-Treasurer and Director Form 3 1
Edward F. Cowle 10% or greater beneficial owner Form 3 1
David Williams 10% or greater beneficial owner Form 3 1
H.D. Williams 10% or greater beneficial owner Form 3 1
The Company is not aware of whether any of the above-named persons engaged in
the buying or selling of the Company's Common Stock after they became subject to
file certain reports, pursuant to Section 16 of the Exchange Act, and does not
know if these persons were required to file any Form 4 or Forms 5, or the number
of such Forms required to be filed, if applicable.
FINANCIAL STATEMENTS OF THE COMPANY
The Audited Financial Statements of the Company for the year ended June 30,
1998 are included in this Proxy Statement.
FINANCIAL STATEMENTS OF SENESCO
The Audited Financial Statements of Senesco for the period of inception
through October 30, 1998 and the Audited Financial Statements of Senesco, LLC
for the period from inception through October 31, 1998, are included in this
Proxy Statement.
CONSOLIDATED PRO FORMA FINANCIAL STATEMENTS
The Consolidated Pro Forma Financial Statements, dated September 30, 1998,
of the Company and Senesco are included in this Proxy Statement.
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
The Company incorporates herein by reference the following documents filed
by it with the Securities and Exchange Commission (File No. 022307) pursuant to
the Exchange Act, copies of which are being delivered to shareholders herewith:
(1) its Annual Report on Form 10-KSB for the fiscal year ended June 30, 1998;
and (2) its Quarterly Report on Form 10-QSB for the quarter ended September 30,
1998.
SHAREHOLDERS' PROPOSALS
As previously disclosed to shareholders in connection with the Company's
1998 Annual Meeting, shareholders who wish to submit proposals for inclusion in
the Company's proxy statement and form of proxy relating to the 1999 Annual
Meeting of Shareholders must submit their proposals
32
in writing to the Secretary at the address set forth on the first page of this
Proxy Statement. Proposals must be received by the Secretary no later than March
31, 1999 for inclusion in next year's proxy statement and proxy card. No
shareholder proposals will be accepted for the Special Meeting.
OTHER MATTERS
The Board of Directors does not intend to present for consideration at the
Special Meeting any business other than the matters referred to in the
accompanying Notice. In the event any other matter should properly come before
the Meeting, the person(s) appointed by the accompanying Proxy will vote on such
other matters in accordance with their best judgment pursuant to the
discretionary authority granted in the Proxy.
The cost of this solicitation of Proxies will be borne by the Company. In
addition to the use of the mails, some of the officers and regular employees of
the Company and/or consultants may solicit Proxies by telephone and telegraph,
or request brokerage houses and other custodian nominees and fiduciaries to
forward soliciting materials to beneficial owners of shares held of record by
such persons and may verify the accuracy of marked Proxies by contacting record
and beneficial owners of the shares. The Company will reimburse such persons
for the reasonable expenses incurred in forwarding such solicitation materials.
DATED this 3/rd/ day of December, 1998.
--
33
NAVA LEISURE USA, INC.
(A DEVELOPMENT STAGE COMPANY)
FINANCIAL STATEMENTS
JUNE 30, 1998
CONTENTS
Independent Auditors' Report......................... 3
Balance Sheet........................................ 4
Statements of Operations............................. 5
Statements of Stockholders' Equity (Deficit)......... 6
Statements of Cash Flows............................. 8
Notes to the Financial Statements.................... 10
[JONES, JENSEN & COMPANY, LLC LETTERHEAD APPEARS HERE]
INDEPENDENT AUDITORS' REPORT
----------------------------
Board of Directors
Nava Leisure USA, Inc.
Salt Lake City, Utah
We have audited the balance sheet of Nava Leisure USA, Inc. (a development
stage company) as of June 30, 1998 and the related statements of
operations, stockholders' equity (deficit) and cash flows for the years
ended June 30, 1998 and 1997 and from inception on April 1, 1964 through
June 30, 1998. These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on
these financial statements based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a test
basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles
used and significant estimates made by management, as well as evaluating
the overall financial statement presentation. We believe that our audits
provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly,
in all material respects, the financial position of Nava Leisure USA, Inc.
as of June 30, 1998 and the results of its operations and its cash flows
for the years ended June 30, 1998 and 1997 and from inception on April 1,
1964 through June 30, 1998 in conformity with generally accepted
accounting principles.
The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. As discussed in Note 3 to the
financial statements, the Company is a development stage company with no
established source of revenues. These conditions raise substantial doubt
about its ability to continue as a going concern. Management's plans
concerning these matters are also described in Note 3. The financial
statements do not include any adjustments that might result from the
outcome of this uncertainty.
/s/ Jones, Jensen & Company
Jones, Jensen & Company
Salt Lake City, Utah
August 5, 1998
NAVA LEISURE USA, INC.
(A Development Stage Company)
Balance Sheet
ASSETS
------
June 30,
1998
------------
CURRENT ASSETS
Cash $ -
------------
Total Current Assets -
------------
TOTAL ASSETS $ -
============
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
----------------------------------------------
CURRENT LIABILITIES
Accounts payable $ 3,100
-------------
Total Current Liabilities 3,100
-------------
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, 5,000,000 shares authorized at $0.001
par value; Series A preferred stock, 1,100,000
shares authorized, -0- shares issued and outstanding -
Series B preferred stock, 100,000 shares authorized
at $1.00 par value; -0- shares issued and outstanding -
Common stock, 50,000,000 shares authorized at $0.0005
par value; 3,000,025 shares issued and outstanding 1,500
Capital in excess of par value 32,019
Deficit accumulated during the development stage (36,619)
--------------
Total Stockholders' Equity (Deficit) (3,100)
--------------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) $ -
==============
The accompanying notes are an integral part of these financial statements.
4
NAVA LEISURE USA, INC.
(A Development Stage Company)
Statements of Operations
From
Inception on
April 1,
For the Years Ended 1964 Through
June 30, June 30,
-------------------------
1998 1997 1998
---------- ----------- --------------
REVENUE $ - $ - $ -
---------- ----------- --------------
EXPENSES (10,374) (7,810) (36,619)
---------- ----------- --------------
NET LOSS $ (10,374) $ (7,810) $ (36,619)
========== =========== ==============
NET LOSS PER SHARE $ (0.00) $ (0.00)
========== ===========
WEIGHTED AVERAGE NUMBER
OF SHARES OUTSTANDING 3,000,025 3,000,025
========== ===========
The accompanying notes are an integral part of these financial statements.
5
NAVA LEISURE USA, INC.
(A Development Stage Company)
Statements of Stockholders' Equity (Deficit)
Deficit
Accumulated
Capital in During the
Common Stock Excess of Development
-------------------
Shares Amount Par Value Stage
--------- -------- ----------- -------------
Balance, April 1, 1965 - $ - $ - $ -
Issuance of common stock for
cash from inception on April 1,
1965 through June 30, 1993 at
approximately $0.0036 per share 3,000,025 1,500 9,250 -
Contribution of capital through
payment of expenses by
shareholder - - 500 -
Net loss from inception
on April 1, 1964 through
June 30, 1993 - - - (13,110)
----------- --------- --------- ---------
Balance, June 30, 1993 3,000,025 1,500 9,750 (13,110)
Contribution of capital through
payment of expenses by
shareholder - - 1,405 -
Net loss for the year
ended June 30, 1994 - - - (2,169)
----------- --------- --------- ---------
Balance, June 30, 1994 3,000,025 1,500 11,155 (15,279)
Contribution of capital through
payment of expenses by
shareholder - - 2,027 -
Net loss for the year
ended June 30, 1995 - - - (1,602)
----------- --------- --------- --------
Balance, June 30, 1995 3,000,025 $ 1,500 $ 13,182 $(16,881)
----------- --------- --------- --------
The accompanying notes are an integral part of these financial statements.
6
NAVA LEISURE USA, INC.
(A Development Stage Company)
Statements of Stockholders' Equity (Deficit) (Continued)
Deficit
Accumulated
Capital in During the
Common Stock Excess of Development
--------------------------
Shares Amount Par Value Stage
------------ ------------ ------------- ----------------
Balance, June 30, 1995 3,000,025 $ 1,500 $ 13,182 $ (16,881)
Contribution of capital through
payment of expenses by
shareholder - - 653 -
Net loss for the year
ended June 30, 1996 - - - (1,554)
------------ ------------ ------------- ----------------
Balance, June 30, 1996 3,000,025 1,500 13,835 (18,435)
Contribution of capital through
payment of expenses by
shareholder - - 7,403 -
Net loss for the year
ended June 30, 1997 - - - (7,810)
------------ ------------- -------------- ----------------
Balance, June 30, 1997 3,000,025 1,500 21,238 (26,245)
Contributed capital - - 10,781 -
Net loss for the year
ended June 30, 1998 - - - (10,374)
------------ ------------- ------------- ----------------
Balance, June 30, 1998 3,000,025 $ 1,500 $ 32,019 $ (36,619)
============ ============= ============= ================
The accompanying notes are an integral part of these financial statements.
7
NAVA LEISURE USA, INC.
(A Development Stage Company)
Statements of Cash Flows
From
Inception on
April 1,
For the Years Ended 1964 Through
June 30, June 30,
-----------------------------------
1998 1997 1998
--------------- ------------- ------------
CASH FLOWS FROM OPERATING
ACTIVITIES
Net loss $ (10,374) $ (7,810) $ (36,619)
Adjustments to reconcile net loss to
cash used by operating activities:
Expenses paid by shareholder 10,781 7,403 22,769
Increase (decrease) in accounts
payable (407) 407 3,100
--------------- ------------ -----------
Net Cash Provided (Used) by
Operating Activities - - (10,750)
--------------- ------------ -----------
CASH FLOWS FORM INVESTING
ACTIVITIES - - -
--------------- ------------ -----------
CASH FLOWS FROM FINANCING
ACTIVITIES
Proceeds from issuance of
common stock - - 10,750
--------------- ------------ -----------
Net Cash Provided (Used) by
Financing Activities - - 10,750
--------------- ------------ -----------
NET INCREASE (DECREASE) IN
CASH AND CASH EQUIVALENTS - - -
CASH AND CASH EQUIVALENTS AT
BEGINNING OF PERIOD - - -
--------------- ------------ -----------
CASH AND CASH EQUIVALENTS AT
END OF PERIOD $ - $ - $ -
=============== ============ ===========
The accompanying notes are an integral part of these financial statements.
8
NAVA LEISURE USA, INC.
(A Development Stage Company)
Statements of Cash Flows
From
Inception on
April 1,
For the Years Ended 1964 Through
June 30, June 30,
------------------------------------
1998 1997 1998
----------- ------------ ------------
SUPPLEMENTAL DISCLOSURES OF
CASH FLOW INFORMATION
Interest paid $ - $ - $ -
Income taxes paid $ - $ - $ -
The accompanying notes are an integral part of these financial statements.
9
NAVA LEISURE USA, INC.
(A Development Stage Company)
Notes to the Financial Statements
June 30, 1998
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
a. Organization
The financial statements presented are those of Nava Leisure USA, Inc.
(a development stage company) (the Company). The Company was
incorporated on April 1, 1964 in the State of Idaho as Felton
Products, Inc. for the purpose of engaging in investing activities.
On October 13, 1987, the Company issued 12,000,000 of its previously
unissued authorized shares to acquire the assets of Copytex. In
connection with this agreement, the Company changed its name to Ink &
Imagers, Inc. On October 3, 1988, the Company rescinded the agreement
with Copytex. The shares issued pursuant to the agreement were
returned and canceled.
On November 30, 1998, the Company entered into an agreement with Nava
Leisure USA, Inc. (Nava), whereby, it would acquire all of the issued
and outstanding stock of Nava in exchange for 18,730,900 shares of its
common stock, 1,002,000 shares of its series A preferred stock and
89,670 shares of its series B preferred stock. In connection with this
agreement, the Company changed its name to Nava Leisure USA, Inc. On
December 15, 1995, the Company rescinded the agreement due to non-
performance by Nava. All shares issued per the agreement were canceled
and the cancellation was shown retroactively. (Note 2).
The Company is currently inactive, and is seeking other business
opportunities through mergers and acquisitions.
b. Accounting Method
The Company's financial statements are prepared using the accrual
method of accounting. The Company has elected a June 30 year end.
c. Net Loss Per Share
The computation of net loss per share of common stock is based on the
weighted average number of shares outstanding during the period.
d. Cash Equivalents
For purposes of the Statement of Cash Flows, the Company considers all
highly liquid investments with an original maturity of three months or
less to be cash equivalents.
10
NAVA LEISURE USA, INC.
(A Development Stage Company)
Notes to the Financial Statements
June 30, 1998
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
e. Provision for Taxes
The Company accounts for income taxes using Statement of Financial
Accounting Standards No. 109, "Accounting for Income Taxes." Under
Statement 109, the liability method is used in accounting for income
taxes.
As of June 30, 1998, the Company had net operating loss carryforwards
of approximately $36,000 that may be offset against future taxable
income through 2013. The tax benefit of the net loss carryforwards is
offset by a valuation allowance of the same amount due to the
uncertainty that the carryforwards will be used before they expire.
f. Stock Split
On October 27, 1988, the Company effected a split of its common shares
outstanding on a 1.5-for-1 basis. The financial statements have been
retroactively restated to reflect the effects of this stock split.
g. Estimates
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates
and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues
and expenses during the reporting period. Actual results could differ
from those estimates.
NOTE 2 - LITIGATION
On September 26, 1994, a shareholder of the Company filed a lawsuit
against the Company and the shareholders (the Shareholders) that
received shares of the of the Company's stock per the exchange
agreement between the Company and Nava Leisure USA, Inc. (a Delaware
corporation). The lawsuit alleged that the terms of the agreement had
not been fulfilled, and that the exchange agreement should be unwound
as a result of the non-performance. The lawsuit also sought damages
from the shareholders in the amount of $35,000 on behalf of the
Company.
On December 11, 1995, a default judgment was recorded in favor of the
shareholder who had filed the lawsuit. The judgment ordered that the
Exchange Agreement be rescinded, that the shares issued per the
Exchange Agreement be returned to the Company, and that the Company be
awarded damages warded. Due to the uncertainty that the Company will
collect any of the damages, the amount has been offset in full by a
valuation allowance.
11
NAVA LEISURE USA, INC.
(A Development Stage Company)
Notes to the Financial Statements
June 30, 1998
NOTE 3 - GOING CONCERN
The Company's financial statements are prepared using generally
accepted accounting principles applicable to a going concern which
contemplates the realization of assets and liquidation of liabilities
in the normal course of business. However, the Company does not have
significant cash or other material assets, nor does it have an
established source of revenues sufficient to cover its operating costs
and to allow it to continue as a going concern. It is the intent of
the Company to seek a merger with an existing, operating company.
Currently, the stockholders are committed to covering all operating
expenses and other costs until sufficient revenues are generated.
NOTE 4 - RELATED PARTY TRANSACTIONS
During the years ended June 30, 1998 and 1997, a shareholder of the
Company paid expenses on its behalf in the amounts of $10,781 and
$7,403, respectively. These amounts were contributed by the
shareholder to the capital of the Company.
12
SENESCO TECHNOLOGIES, INC.
(FORMERLY NAVA LEISURE USA, INC.)
(A DEVELOPMENT STAGE COMPANY)
CONSOLIDATED PRO FORMA FINANCIAL STATEMENTS
SEPTEMBER 30, 1998
C O N T E N T S
Consolidated Pro forma Balance Sheet................. 3
Consolidated Pro forma Statement of Operations....... 5
Statement of Assumptions and Disclosures............. 6
SENESCO TECHNOLOGIES, INC.
(Formerly Nava Leisure USA, Inc.)
(A Development Stage Company)
Consolidated Pro forma Balance Sheet
September 30, 1998
(Unaudited)
ASSETS
------
Proforma
Senesco Adjustments
Technologies, Senesco, Increase Proforma
Inc. LLC (Decrease) Consolidated
------------- -------- ------------ ------------
CURRENT ASSETS
Cash $ - $ - $ - $ -
------------- -------- ----------- ------------
Total Current Assets - - - -
------------- -------- ----------- ------------
OTHER ASSETS
Patent costs - 16,417 - 16,417
------------- -------- ----------- ------------
Total Other Assets - 16,417 - 16,417
------------- -------- ----------- ------------
TOTAL ASSETS $ - $ 16,417 $ - $ 16,417
============= ======== =========== ============
See Summary of Assumptions and Disclosures.
3
SENESCO TECHNOLOGIES, INC.
(Formerly Nava Leisure USA, Inc.)
(A Development Stage Company)
Consolidated Pro forma Balance Sheet (Continued)
September 30, 1998
(Unaudited)
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
----------------------------------------------
Proforma
Senesco Adjustments
Technologies, Senesco, Increase Proforma
Inc. LLC (Decrease) Consolidated
-------------- ---------- ------------ -------------
CURRENT LIABILITIES
Accounts payable $ 3,100 $ - $ 25,000 $ 28,100
Accrued expenses - 36,417 - 36,417
------------- --------- ----------- ------------
Total Current Liabilities 3,100 36,417 25,000 64,517
------------- --------- ----------- ------------
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock; 5,000,000
shares authorized at $0.001
par value:
Series A Preferred Stock,
1,100,000 shares
authorized, shares
issued and outstanding - - - -
Series B Preferred Stock,
100,000 shares authorized
at $1.00 par value; -0-
shares issued and
outstanding - - - -
Common stock; 50,000,000
shares authorized at
$0.0005 par value,
2,698,413 shares issued
and outstanding 1,500 - (151) 1,349
Additional paid-in capital 32,884 89,110 (62,333) 59,661
Accumulated deficit (37,484) (109,110) 37,484 (109,110)
------------- --------- ----------- ------------
Total Stockholders' Equity
(Deficit) (3,100) (20,000) (25,000) (48,100)
------------- --------- ----------- ------------
TOTAL LIABILITIES AND
STOCKHOLDERS'
EQUITY (DEFICIT) $ - $ 16,417 $ - $ 16,417
============= ========= =========== ============
See Summary of Assumptions and Disclosures.
4
SENESCO TECHNOLOGIES, INC.
(Formerly Nava Leisure USA, Inc.)
(A Development Stage Company)
Consolidated Statement of Operations
September 30, 1998
(Unaudited)
Proforma
Senesco Adjustments
Technologies, Senesco, Increase Proforma
Inc. LLC (Decrease) Consolidated
-------------- ---------- ------------ -------------
REVENUES $ - $ - $ - $ -
-------- ---------- ----------- ------------
EXPENSES
General and administrative 10,374 109,110 - 119,484
-------- ---------- ----------- ------------
Total Expenses 10,374 109,110 - 119,484
-------- ---------- ----------- ------------
LOSS FROM OPERATIONS (10,374) (109,110) - (119,484)
-------- ---------- ----------- ------------
NET LOSS $(10,374) $ (109,110) $ - $ (119,484)
======== ========== =========== ============
BASIC NET LOSS PER SHARE $ (0.01) $ (0.06) $ (0.04)
======== ========== ============
BASIC WEIGHTED AVERAGE
NUMBER OF SHARES
OUTSTANDING 998,413 1,700,000 2,698,413
======== ========== ============
See Summary of Assumptions and Disclosures.
5
SENESCO TECHNOLOGIES, INC.
(Formerly Nava Leisure USA, Inc.)
(A Development Stage Company)
September 30, 1998
(Unaudited)
BACKGROUND AND HISTORICAL INFORMATION
The financial statements presented are those of Senesco Technologies,
Inc. (a development stage company) (the Company). The Company was
incorporated on April 1, 1964 in the State of Idaho as Felton Products,
Inc. for the purpose of engaging in investing activities.
On October 13, 1987, the Company issued 12,000,000 of its previously
unissued authorized shares to acquire the assets of Copytex. In
connection with this agreement, the Company changed its name to Ink &
Imagers, Inc. On October 3, 1988, the Company rescinded the agreement
with Copytex. The shares issued pursuant to the agreement were returned
and canceled.
On November 30, 1998, the Company entered into an agreement with Nava
Leisure USA, Inc, (Nava), whereby, it would acquire all of the issued and
outstanding stock of Nava in exchange for 18,730,900 shares of its common
stock, 1,002,000 shares of its Series A preferred stock and 89,670 shares
of its Series B preferred stock. In connection with this agreement, the
Company changed its name to Nava Leisure USA, Inc. On December 15, 1995,
the Company rescinded the agreement due to non-performance by Nava. All
shares issued per the agreement were canceled and the cancellation was
shown retroactively.
The Company was inactive, and was seeking other business opportunities
through mergers and acquisition.
Senesco, LLC (SLCC) was formed in June 1998 to commercially exploit
potentially significant technology in connection with the identification
and characterization of a gene (a lipase gene) which controls the aging
of plants (flowers, fruits and vegetables).
SLCC has formulated a Phase One research and development plan to attempt
to further characterize the gene in flowers, fruits and vegetables.
Senescence in plant tissues is the natural aging of these tissues. Loss
of cellular membrane integrity attributable to lipase gene activity is an
early event during the senescensce of all plant tissues that prompts the
deterioration of fresh flowers, fruits and vegetables. This loss of
integrity is attributable to the formation of lipid metabolites in
membrane bi-layers that "phase-separate" and cause the membranes to
become "leaky". A decline in cell function ensues leading to
deterioration and eventual death (spoilage of the tissue).
Presently, the technology utilized for controlling senescence and
increasing the shelf life of flowers, fruits and vegetables relies on
reducing ethylene biosynthesis, and hence only has application to a
limited number of plants that are ethylene-sensitive. SLCC is researching
a plan to avoid this limitation since Senesco believes that the lipase
gene is present in all plants.
6
SENESCO TECHNOLOGIES, INC.
(Formerly Nava Leisure USA, Inc.)
(A Development Stage Company)
September 30, 1998
(Unaudited)
BACKGROUND AND HISTORICAL INFORMATION (Continued)
Currently, SLLC's research and development plan focuses on gene
characterization of carnation for flowers, tomato for fruits, and
Arabidopsis thaliana for (leafy) vegetables. In addition, SLLC expects to
enter into a joint venture with an Israeli company. The joint venture is
expected to be based on the contribution by SLLC of its gene technology
and Rahan Meristem's know-how in banana fruit. Rahan Meristem is in the
business of worldwide export marketing in genetically engineered banana
plants.
The inventor of SLLC's technology is John E. Thompson, Ph.D., who is the
Dean of Science at the University of Waterloo in Waterloo, Ontario. SLLC
is currently negotiating a three-year research and development agreement
with Dr. Thompson and the University of Waterloo.
SLLC filed a patent application on June 26, 1998 to protect the above-
described developments/inventions.
PROFORMA TRANSACTIONS
The historical financial information contained herein has been
consolidated assuming the issuance of 1,700,000 common stock of Senesco
Technologies, Inc. (STI) for 100% of the outstanding common stock of
Senesco, LLC. as of September 30, 1998. The purchase has been
retroactively applied to the historical information of these companies.
The balance sheet of Senesco Technologies, Inc. is shown as of September
30, 1998 and the balance sheet of Senesco, LLC (SLLC) is shown as of
September 30, 1998. The statement of operation of Senesco Industries,
Inc. is for the year ended June 30, 1998 and the statement of operations
of Senesco, LLC is from inception through September 30, 1998.
Senesco Technologies, Inc. issued 1,700,000 shares of common stock in
exchange for 100% of the outstanding interests of Senesco, LLC. The
proforma adjustments have been accounted for as a recapitalization of
SLLC because the members of SLLC control the Company after the
acquisition. Therefore, SLLC is treated as the acquiring entity.
Accordingly, there was no adjustment to the carrying value of the assets
or liabilities of SLLC. STI is the acquiring entity for legal purposes
and SLLC is the surviving entity for accounting purposes.
1. Record the purchase of Senesco, LLC. through the issuance of
1,700,000 shares of common stock:
Common stock $ 850
Additional paid-in capital (850)
-----
Total $ -
=====
7
SENESCO TECHNOLOGIES, INC.
(Formerly Nava Leisure USA, Inc.)
(A Development Stage Company)
September 30, 1998
(Unaudited)
PROFORMA TRANSACTIONS (Continued)
2) Record the estimated costs of the merger:
Accounts payable $ 25,000
Additional paid-in capital (25,000)
-----------
Total $ -
===========
3) Eliminate the deficit of Senesco Technologies, Inc.:
Accumulated deficit $ (37,484)
Additional paid-in capital 37,484
-----------
Total $ -
===========
4) Record a 1 share for 3 shares reverse split of Senesco Technologies, Inc.:
Common stock $ (1,001)
Additional paid-in capital 1,001
-----------
Total $ -
===========
8
THOMAS P. MONAHAN
CERTIFIED PUBLIC ACCOUNTANT
208 LEXINGTON AVENUE
PATERSON, NEW JERSEY 07502
(973) 790-8775
To the Members of
Senesco, LLC
A New Jersey Limited Liability Company
(a development stage company)
I have audited the accompanying balance sheet of Senesco, LLC (a development
stage company) as at October 31, 1998, and the related statements of income and
members' equity and cash flows for the period from inception, June 25, 1998, to
October 31, 1998. These financial statements are the responsibility of the
Company's management. My responsibility is to express an opinion on these
financial statements based on our audit.
I conducted my audit in accordance with generally accepted auditing standards.
Those standards require that I plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
I believe that my audit provides a reasonable basis for our opinion.
In my opinion, the financial statements referred to above present fairly, in all
material respects, the financial position of Senesco, LLC (a development stage
company) as at October 31, 1998 and the results of its operations and its cash
flows for the period from inception, June 25, 1998, to October 31, 1998 in
conformity with generally accepted accounting principles.
The accompanying financial statements have been prepared assuming that Senesco,
LLC ( a development stage company) will continue as a going concern. As more
fully described in Note 2, the Company has incurred operating losses since
inception and requires additional capital to continue operations. These
conditions raise substantial doubt about the Company's ability to continue as a
going concern. Management's plans as to these matters are described in Note 2.
The financial statements do not include any adjustments to reflect the possible
effects on the recoverability and classification of assets or the amounts and
classifications of liabilities that may result from the possible inability of
Senesco, LLC (a development stage company) to continue as a going concern.
/s/ Thomas Monahan
- ------------------
November 27, 1998
SENESCO, LLC
A NEW JERSEY LIMITED LIABILITY COMPANY
(A DEVELOPMENT STAGE COMPANY)
BALANCE SHEET
OCTOBER 31, 1998
ASSETS
Current assets
Cash and cash equivalents $-0-
----
Current assets -0-
Other assets
Patent costs 16,417
------
Total other assets 16,417
------
Total assets $16,417
=======
LIABILITIES AND MEMBERS' EQUITY
Current liabilities
Accrued expenses $36,417
------
Total current liabilities 36,417
Members' Equity (20,000)
-------
Total liabilities and members' equity $16,417
========
See accompanying notes to financial statements.
F2
SENESCO, LLC
A NEW JERSEY LIMITED LIABILITY COMPANY
(A DEVELOPMENT STAGE COMPANY)
STATEMENT OF OPERATIONS
FOR THE PERIOD FROM INCEPTION, JUNE 25, 1998, TO OCTOBER 31, 1998
Revenue $-0-
Costs of goods sold -0-
Gross profit -0-
Operations:
General and administrative 109,110
Depreciation and amortization -0-
----
Total expense 109,110
Income (loss) (109,110)
See accompanying notes to financial statements.
F3
SENESCO, LLC
A NEW JERSEY LIMITED LIABILITY COMPANY
(A DEVELOPMENT STAGE COMPANY)
STATEMENT OF CASH FLOWS
FOR THE PERIOD FROM INCEPTION, JUNE 25, 1998, TO OCTOBER 31, 1998
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) $(109,110)
Depreciation -0-
Adjustments to reconcile net income (loss) to net cash
Accrued expenses 36,417
------
TOTAL CASH FLOWS FROM OPERATIONS (72,693)
CASH FLOWS FROM INVESTING ACTIVITIES
Patent costs (16,417)
--------
TOTAL CASH FLOWS FROM INVESTING ACTIVITIES (16,417)
CASH FLOWS FROM FINANCING ACTIVITIES
Members' equity contribution 89,110
------
TOTAL CASH FLOWS FROM FINANCING ACTIVITIES 89,110
NET INCREASE (DECREASE) IN CASH -0-
CASH BALANCE BEGINNING OF PERIOD -0-
----
CASH BALANCE END OF PERIOD $-0-
=====
See accompanying notes to financial statements.
F4
SENESCO, LLC
A NEW JERSEY LIMITED LIABILITY COMPANY
(A DEVELOPMENT STAGE COMPANY)
STATEMENT OF MEMBERS' EQUITY
June 25, 1998 Beginning Members' $-0-
Equity
Members' contribution $ 89,110
Net loss (109,110)
---------
October 31, 1998 Ending Members' $ (20,000)
deficit =========
See accompanying notes to financial statements.
F5
SENESCO, LLC
A NEW JERSEY LIMITED LIABILITY COMPANY
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS
Note 1. ORGANIZATION OF COMPANY AND ISSUANCE OF COMMON STOCK
----------------------------------------------------
a. Creation of the Company
Senesco, LLC, (the "Company") was formed under the laws of New Jersey on
June 25, 1998 as a New Jersey Limited Liability Company.
b. Description of the Company
The Company is a development stage company that was organized to
commercially exploit technology acquired and developed in connection with the
identification and characterization of a gene which controls the aging of
fruits, vegetables and flowers.
NOTE 2-SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
------------------------------------------
a. Basis of Financial Statement Presentation
The accompanying financial statements have been prepared on a going concern
basis, which contemplates the realization of assets and the satisfaction of
liabilities in the normal course of business. On June 25, 1998, the Company
acquired a certain patent application. The Company has not generated any income
and has been dependent upon management to pay the expenses to maintain the
Company's existence and pay the costs of acquiring the patent. These factors
indicate that the Company's continuation as a going concern is dependent upon
its ability to obtain adequate financing.
The financial statements presented consist of the balance sheet of the
Company as at October 31, 1998 and the related statements of operations,
members' capital and cash flows for the period from inception, June 25, 1998, to
October 31, 1998.
b. Cash and cash equivalents
The Company treats temporary investments with a maturity of less than three
months as cash.
c. Revenue recognition
Revenue is recognized when products are shipped or services are rendered.
d. Selling and Marketing Costs
Selling and Marketing - Certain selling and marketing costs are expensed in
the period in which the cost pertains. Other selling and marketing costs are
expensed as incurred.
e. Use of Estimates
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that effect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the
F6
SENESCO, LLC
A NEW JERSEY LIMITED LIABILITY COMPANY
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS
financial statements and the reported amounts of revenues and expenses during
the reporting period. Actual results could differ from those estimates.
f. Asset Impairment
The Company adopted the provisions of SFAS No. 121, Accounting for the
impairment of long lived assets and for long-lived assets to be disposed of
effective January 1, 1996. SFAS No. 121 requires impairment losses to be
recorded on long-lived assets used in operations when indicators of impairment
are present and the estimated undiscounted cash flows to be generated by those
assets are less than the assets' carrying amount. SFAS No. 121 also addresses
the accounting for long-lived assets that are expected to be disposed of. There
was no effect of such adoption on the Company's financial position or results of
operations.
g. Research and Development Expenses
Research and development expenses are charged to operations when incurred.
h. Patent Costs
Costs incurred to acquire exclusive licenses of patentable technology
are capitalized and amortized over the shorter of a five year period or the term
of the license or patent. The portion of these amounts determined to be
attributable to patents is amortized over their remaining lives and the
remainder is amortized over the estimated period of benefit but not more than 40
years on a straight line basis.
i. Income Taxes
The Company is a limited liability company treated as a partnership for
income tax reporting purposes and, as such, is not subject to income tax.
Accordingly, no provision for income taxes is provided in the financial
statements. The income tax liability of the individual members is not accrued on
the books of the Company.
NOTE 3 - MEMBERSHIP CAPITAL
The Company is a New Jersey Limited Liability Company formed on June 25,
1998 with the following Membership Interests:
Phillippe Escaravage 55.381%
Michel Escaravage 13.845%
John Bradley 0.486%
John Thompson 25.000%
Yuwen Hong 1.000%
Katalin Hudak 1.000%
Sascha Fedyszyn 1.099%
Christian Ahrens 0.486%
Steven Katz 1.460%
Christopher Forbes 0.243%
-----
100.000%
F7
SENESCO, LLC
A NEW JERSEY LIMITED LIABILITY COMPANY
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS
NOTE 4 - MARKETABLE SECURITIES, AVAILABLE FOR SALE
The Company adopted Financial Accounting Standards Board ("FASB") Statement
No. 115, "Accounting for Certain Investments in Debt and Equity Securities",
which requires that investments in equity securities that have readily
determinable fair values and investments in debt securities be classified in
three categories: held-to-maturity, trading and available-for-sale. Based on the
nature of the assets held by the Company and Management's investment strategy,
the Company's investments have been classified as available-for-sale. Management
determines the appropriate classification of debt securities at the time of
purchase and reevaluates such designation as of each balance sheet date.
Securities classified as available-for-sale are carried at estimated fair
value, as determined by quoted market prices, with unrealized gains and losses,
net of tax, reported in a separate component of stockholders' equity. At October
31, 1998, the Company had no investments that were classified as trading or
held-to-maturity as defined by the Statement.
NOTE 5 - RELATED PARTY TRANSACTIONS
--------------------------
a. Transfer of Patent
On June 25, 1998, John E. Thompson, Yuwen Hong and Katalin A. Hudak filed a
U.S. Patent Application in connection with the identification and
characterization of a gene which controls the aging of plants. On June 25, 1998,
these individuals assigned their rights and ownership of the patent to this
technology including current and future patents to the Company in exchange for
Membership as follows: John E. Thompson, 25%; Yuwen Hong, 1% and Katalin A.
Hudak, 1 %.
b. Member Contribution
Mr. Phillippe Escaravage caused to be paid on behalf of the Company $89,110
in expenses of the Company for the period from inception, June 25, 1998, to
October 31, 1998. This contributed amount was treated as an increase in Members'
Equity.
c. Common Management
Mr. Phillippe Escaravage is the Managing Member of the Company and
President of Escaravage Biological Industries, LLC.
NOTE 6 - COMMITMENTS AND CONTINGENCIES
a. Consulting Services
The Company has accrued $20,000 in consulting fees due Mr. Steven Katz, a
Member, as of October 31, 1998.
F8
SENESCO, LLC
A NEW JERSEY LIMITED LIABILITY COMPANY
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS
b. Consulting Agreement
On June 26, 1998, the Company entered into a 3 year exclusive research and
development Consulting Agreement, beginning July 1, 1998, with Dr. John E.
Thompson, Dean of Science at the University of Waterloo, Waterloo, Ontario. The
Consulting Agreement is automatically renewable for 2 additional three-year
terms, unless either of the parties notifies the other with written notice. The
Company is obligated to reimburse Dr. Thompson for reasonable traveling and
living expenses. Mr. Thompson has agreed to not compete and to assign to the
Company his entire right, title and interest to any inventions or improvements
during the course of this agreement and for a period of 1 year after the
conclusion of this agreement. Dr. Thompson has also agreed to act as an
independent contractor and is not eligible to participate in any benefits
extended by the Company to its employees.
c. Lease of Office Space
The Company subleases office space at 11 Chambers Street, Princeton, New
Jersey from Escaravage Biological Industries, LLC at $400 per month on a month
to month lease.
NOTE 7 - SUBSEQUENT EVENTS
a. Research Agreement
Subsequent to the date of the financial statements, the Company entered
into a research agreement with the University of Waterloo, Waterloo, Ontario,
Canada, ("Waterloo"), pursuant to which Dr. Thompson will utilize the facilities
and staff at Waterloo University to perform research and development services
under the guidance of Dr. Thompson. Waterloo agrees to assign to the Company all
rights, title and interest to any technology and inventions made, conceived of
or arising this agreement.
b. Sale of the Company
Subsequent to the date of the financial statements, the Company entered
into a series of agreements as follows:
The Company entered into an Agreement and Plan of Merger (the "Agreement"),
with Senesco of New Jersey, Inc. ("Senesco, Inc."), pursuant to which the
Company exchanged all the membership interests in the Company for an aggregate
of 1,700,000 shares of common stock of Senesco, Inc. The shares of common stock
were divided amongst the Members in the same ratio as the Membership interests.
Mr. Phillippe Escaravage is the President of Senesco, Inc.
The transaction has been accounted for as a transfer and is accounted for
at historical cost as a pooling of interests with the recording of the net
assets acquired at their historical book value.
On October 2, 1998, the Company entered into a Letter of Intent with Nava
Leisure USA Inc. ("Leisure"), pursuant to which Leisure would acquire the
assets of the Company through
F9
SENESCO, LLC
A NEW JERSEY LIMITED LIABILITY COMPANY
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS
Leisure's subsidiary Nava Leisure Acquisition Corp. ("Acquisition Corp.") in
exchange for 1,700,000 shares of Leisure's common stock. Acquisition Corp. would
be the surviving entity.
As part of the agreement, the Company was to transfer its assets including
the Company's patents, technologies and related agreements to Senesco, Inc.
F10
THOMAS P. MONAHAN
CERTIFIED PUBLIC ACCOUNTANT
208 LEXINGTON AVENUE
PATERSON, NEW JERSEY 07502
(973) 790-8775
To the Shareholders of
Senesco, Inc.
(a development stage company)
I have audited the accompanying balance sheet of Senesco, Inc. (a development
stage company) as at November 30, 1998, and the related statements of income and
members' equity and cash flows for the period from inception, November 25, 1998,
to November 30, 1998. These financial statements are the responsibility of the
Company's management. My responsibility is to express an opinion on these
financial statements based on our audit.
I conducted my audit in accordance with generally accepted auditing standards.
Those standards require that I plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
I believe that my audit provides a reasonable basis for our opinion.
In my opinion, the financial statements referred to above present fairly, in all
material respects, the financial position of Senesco, Inc. (a development stage
company) as at November 30, 1998 and the results of its operations and its cash
flows for the period from inception, November 25, 1998, to November 30, 1998 in
conformity with generally accepted accounting principles.
The accompanying financial statements have been prepared assuming that Senesco,
Inc. ( a development stage company) will continue as a going concern. As more
fully described in Note 2, the Company has incurred operating losses since
inception and requires additional capital to continue operations. These
conditions raise substantial doubt about the Company's ability to continue as a
going concern. Management's plans as to these matters are described in Note 2.
The financial statements do not include any adjustments to reflect the possible
effects on the recoverability and classification of assets or the amounts and
classifications of liabilities that may result from the possible inability of
Senesco, Inc. (a development stage company) to continue as a going concern.
/s/ Thomas Monahan
- ------------------
December 1, 1998
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
BALANCE SHEET
NOVEMBER 30, 1998
ASSETS
Current assets
Cash and cash equivalents $-0-
----
Current assets -0-
Other assets
Patent costs 16,417
-------
Total other assets 16,417
-------
Total assets $16,417
========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accrued expenses $36,417
------
Total current liabilities 36,417
Stockholders' equity
Common Stock authorized 2,000,000 shares, no-par value each. 89,110
At November 30, 1998, there are 1,700,000 shares outstanding
Deficit accumulated during development stage (109,110)
---------
Total stockholders' equity (20,000)
---------
Total liabilities and stockholders' equity $16,417
=========
See accompanying notes to financial statements.
F2
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
STATEMENT OF OPERATIONS
FOR THE PERIOD FROM INCEPTION, NOVEMBER 25, 1998, TO NOVEMBER 30, 1998
Revenue $-0-
Costs of goods sold -0-
----
Gross profit -0-
Operation:
General and administrative 109,110
Depreciation and amortization -0-
----
Total expense 109,110
Income (loss) (109,110)
========
Net income (loss) per share-basic $(.06)
======
Number of shares outstanding-basic 1,700,000
=========
See accompanying notes to financial statements.
F3
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
STATEMENT OF CASH FLOWS
FOR THE PERIOD FROM INCEPTION, , 1998, TO NOVEMBER 30, 1998
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) $(109,110)
Depreciation -0-
Adjustments to reconcile net income (loss) to net cash
Accrued expenses 36,417
------
TOTAL CASH FLOWS FROM OPERATIONS (72,693)
CASH FLOWS FROM INVESTING ACTIVITIES
Patent costs (16,417)
--------
TOTAL CASH FLOWS FROM INVESTING ACTIVITIES (16,417)
CASH FLOWS FROM FINANCING ACTIVITIES
Members' equity contribution 89,110
--------
TOTAL CASH FLOWS FROM FINANCING ACTIVITIES 89,110
NET INCREASE (DECREASE) IN CASH -0-
CASH BALANCE BEGINNING OF PERIOD -0-
----
CASH BALANCE END OF PERIOD $-0-
====
See accompanying notes to financial statements.
F4
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
STATEMENT OF STOCKHOLDERS EQUITY
Deficit accumulated
Common Common during development
Date Stock Stock stage Total
- ---- ----- ----- ----- -----
11-30-1998 1,700,000 $89,110 $(109,110) $(20,000)
========= ======= ========== =========
See accompanying notes to financial statements.
F5
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS
NOVEMBER 30, 1998
NOTE 1. ORGANIZATION OF COMPANY AND ISSUANCE OF COMMON STOCK
----------------------------------------------------
a. Creation of the Company
Senesco, Inc., (the "Company") was formed under the laws of New Jersey on
November 25, 1998 and is authorized to issue 2,000,000 shares of common stock,
no-par value each.
b. Description of the Company
The Company is a development stage company that was organized as a
successor to Senesco, LLC ("Senesco") to commercially exploit technology
acquired and developed in connection with the identification and
characterization of a gene which controls the aging of fruits, vegetables and
flowers. There was no predecessor entity to Senesco, LLC.
c. Issuance of Shares of Common Stock
On November 30, 1998, the Company issued 1,700,000 shares of common stock
to the Members of Senesco in exchange for Senesco's assets and the interests and
rights to Senesco's technologies and patents. The transaction was treated using
the pooling of interest method of accounting with historic costs being the basis
of the transfer of account balances to the Company.
NOTE 2-SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
------------------------------------------
a. Basis of Financial Statement Presentation
The accompanying financial statements have been prepared on a going concern
basis, which contemplates the realization of assets and the satisfaction of
liabilities in the normal course of business. On June 25, 1998, Senesco acquired
a certain patent application. Neither the Company nor Senesco has generated any
income and has been dependent upon management to pay the expenses to maintain
the Company's existence and pay the costs of acquiring the patent. These factors
indicate that the Company's continuation as a going concern is dependent upon
its ability to obtain adequate financing.
The pro forma financial statements presented consist of the balance sheet
of the Company as at November 30, 1998 and the related statements of operations,
members' capital and cash flows for the period from inception, November 25,
1998, to November 30, 1998. Senesco, Inc's. fiscal year end is December 31.
b. Cash and cash equivalents
The Company treats temporary investments with a maturity of less than three
months as cash.
c. Revenue recognition
Revenue is recognized when products are shipped or services are
rendered.
F6
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS
NOVEMBER 30, 1998
d. Selling and Marketing Costs
Selling and Marketing - Certain selling and marketing costs are expensed in
the period in which the cost pertains. Other selling and marketing costs are
expensed as incurred.
e. Use of Estimates
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that effect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
f. Asset Impairment
The Company adopted the provisions of SFAS No. 121, Accounting for the
impairment of long lived assets and for long-lived assets to be disposed of
effective January 1, 1996. SFAS No. 121 requires impairment losses to be
recorded on long-lived assets used in operations when indicators of impairment
are present and the estimated undiscounted cash flows to be generated by those
assets are less than the assets' carrying amount. SFAS No. 121 also addresses
the accounting for long-lived assets that are expected to be disposed of. There
was no effect of such adoption on the Company's financial position or results of
operations.
g. Research and Development Expenses
Research and development expenses are charged to operations when incurred.
h. Patent Costs
Costs incurred to acquire exclusive licenses of patentable technology
are capitalized and amortized over the shorter of a five year period or the term
of the license or patent. The portion of these amounts determined to be
attributable to patents is amortized over their remaining lives and the
remainder is amortized over the estimated period of benefit but not more than 40
years on a straight line basis.
NOTE 3 - TRANSFER OF ASSETS
The Company entered into an Agreement and Plan of Merger (the "Agreement"),
with Senesco, pursuant to which the Company exchanged all the membership
interests in Senesco for an aggregate of 1,700,000 shares of common stock of the
Company. The shares of common stock were divided amongst the Members of Senesco
in the same ratio as the Membership interests. Mr. Phillippe Escaravage is the
President of Senesco, Inc.
The transaction has been accounted for as a transfer and is accounted for
at historical cost as a pooling of interests with the recording of the net
assets acquired at their historical book value.
F7
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS
NOVEMBER 30, 1998
On October 2, 1998, the Company entered into a Letter of Intent with Nava
Leisure USA Inc. ("Leisure"), pursuant to which Leisure would acquire the
assets of the Company through Leisure's subsidiary Nava Leisure Acquisition
Corp. ("Acquisition Corp.") in exchange for 1,700,000 shares of Leisure's common
stock. Acquisition Corp. would be the surviving entity.
As part of the agreement, the Company was to transfer its assets including
the Company's patents, technologies and related agreements from Senesco.
NOTE 4 - MARKETABLE SECURITIES, AVAILABLE FOR SALE
The Company adopted Financial Accounting Standards Board ("FASB") Statement
No. 115, "Accounting for Certain Investments in Debt and Equity Securities",
which requires that investments in equity securities that have readily
determinable fair values and investments in debt securities be classified in
three categories: held-to-maturity, trading and available-for-sale. Based on the
nature of the assets held by the Company and Management's investment strategy,
the Company's investments have been classified as available-for-sale. Management
determines the appropriate classification of debt securities at the time of
purchase and reevaluates such designation as of each balance sheet date.
Securities classified as available-for-sale are carried at estimated fair
value, as determined by quoted market prices, with unrealized gains and losses,
net of tax, reported in a separate component of stockholders' equity. At October
31, 1998, the Company had no investments that were classified as trading or
held-to-maturity as defined by the Statement.
NOTE 5 - RELATED PARTY TRANSACTIONS
--------------------------
a. Transfer of Patent
On June 25, 1998, John E. Thompson, Yuwen Hong and Katalin A. Hudak filed a
U.S. Patent Application in connection with the identification and
characterization of a gene which controls the aging of plants. On June 25, 1998,
these individuals assigned their ownership of the patent to this technology
including current and future patents to Senesco in exchange for Membership as
follows: John E. Thompson, 25%; Yuwen Hong, 1% and Katalin A. Hudak, 1 %.
b. Member Contribution
Mr. Phillippe Escaravage caused to be paid on behalf of Senesco, $89,110 in
expenses of Senesco for the period from inception, June 25, 1998, to October 31,
1998. This contributed amount was treated as an increase in Members' Equity in
Senesco.
c. Common Management
Mr. Phillippe Escaravage is the Managing Member of the Company, President
of Escaravage Biological Industries, LLC. and President of Senesco.
F8
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS
NOVEMBER 30, 1998
NOTE 6 - COMMITMENTS AND CONTINGENCIES
The Company has acquired through the acquisition of Senesco certain
relationships as follows:
a. Consulting Services
Senesco has accrued $20,000 in consulting fees due Mr. Steven Katz, a
Member, as of October 31, 1998.
b. Consulting Agreement
On June 26, 1998, the Senesco entered into a 3 year exclusive research and
development Consulting Agreement, beginning July 1, 1998, with Dr. John E.
Thompson, Dean of Science at the University of Waterloo, Waterloo, Ontario. The
Consulting Agreement is automatically renewable for 2 additional three-year
terms, unless either of the parties notifies the other with written notice. The
Company is obligated to reimbuse Dr. Thompson for reasonable traveling and
living expenses. Mr. Thompson has agreed to not compete and to assign to the
Company his entire right, title and interest to any inventions or improvements
during the course of this agreement and for a period of 1 year after the
conclusion of this agreement. Dr. Thompson has also agreed to act as an
independent contractor and is not eligible to participate in any benefits
extended by the Company to its employees.
c. Lease of Office Space
The Company subleases office space at 11 Chambers Street, Princeton, New
Jersey from Escaravage Biological Industries, LLC at $400 per month on a month
to month lease.
NOTE 7 - SUBSEQUENT EVENTS
Research Agreement
Subsequent to the date of the financial statements, Senesco entered into a
research agreement with the University of Waterloo, Waterloo, Ontario, Canada,
("Waterloo"), pursuant to which Dr. Thompson will utilize the facilities and
staff at Waterloo University to perform research and development services under
the guidance of Dr. Thompson. Waterloo agrees to assign to Sernesco and the
Company all rights, title and interest to any technology and inventions made,
conceived of or arising this agreement.
NOTE 8 - INCOME TAXES
------------
The Company provides for the tax effects of transactions reported in the
financial statements. The provision if any, consists of taxes currently due plus
deferred taxes related primarily to differences between the basis of assets and
liabilities for financial and income tax reporting. The deferred tax assets and
liabilities, if any represent the future tax return consequences of those
differences, which will either be taxable or deductible when the assets and
liabilities are recovered or settled. As of November 30, 1998, the Company had
no material
F9
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS
NOVEMBER 30, 1998
current tax liability, deferred tax assets, or liabilities to impact on the
Company's financial position because the deferred tax asset related to the
Company's net operating loss carryforward and was fully offset by a valuation
allowance.
At November 30, 1998, the Company has net operating loss carry forwards for
income tax purposes of $109,110. This carryforward is available to offset future
taxable income, if any, and expires in the year 2010. The Company's utilization
of this carryforward against future taxable income may become subject to an
annual limitation due to a cumulative change in ownership of the Company of more
than 50 percent.
The components of the net deferred tax asset as of November 30, 1998 are as
follows:
Deferred tax asset:
Net operating loss carry forward $ 37,097
Valuation allowance $(37,097)
--------
Net deferred tax asset $ -0-
========
The Company recognized no income tax benefit for the loss generated in the
period from inception, November 25, 1998 to November 30, 1998.
SFAS No. 109 requires that a valuation allowance be provided if it is more
likely than not that some portion or all of a deferred tax asset will not be
realized. The Company's ability to realize benefit of its deferred tax asset
will depend on the generation of future taxable income. Because the Company has
yet to recognize significant revenue from the sale of its products, the Company
believes that a full valuation allowance should be provided.
F10
SENESCO, INC.
PRO FORMA CONDENSED FINANCIAL STATEMENTS
(UNAUDITED)
The following unaudited pro forma combined condensed financial statements
present a combined balance sheet and related statements of income of Senesco,
Inc. giving effect to the acquisition and using the pooling of interest method
of accounting for the proposed merger pursuant to a Agreement and Plan of Merger
(the "Agreement"), by exchange of assets for Common Stock which was dated on
November 25, 1998.
The proposed merger is reflected using the pooling of interest method of
accounting, whereby Senesco, Inc. issued 1,700,000 shares of common stock in
exchange for all of the Membership Interest in Senesco, LLC.
The pro forma financial statements are presented as if the contemplated
merger between the Company, and Senesco, LLC. had been completed. After giving
effect to this transaction the financial statements consist of the pro forma
balance sheet of the Company as at November 30, 1998 and the related statements
of operations, Stockholders' equity and cash flows for period from inception,
November 25, 1998 and the pro forma balance sheet of Senesco, LLC at October 31,
1998 and the related pro forma statements of operations, stockholders' equity
and cash flows for the period from inception, June 25, 1998, to October 31,
1998. The information shown is based upon numerous assumptions and estimates and
is not necessarily indicative of the results of future operations of the
combined entities or the actual results that would have occurred had the
transaction been consummated during the periods indicated. These statements
should be read in conjunction with the consolidated financial statements of
Senesco, Inc. and Senesco, LLC included herein.
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
PRO FORMA BALANCE SHEET
NOVEMBER 30, 1998
Senesco, Inc. Senesco, LLC Adjustments Senesco, Inc.
ASSETS
Current assets
Cash and cash equivalents $-0- $-0- $-0- $-0-
---- ---- ---- ----
Current assets -0- -0- -0- -0-
Other assets
Patent costs 16,417 16,417
------ ------
Total other assets 16,417 16,417
------ ------
Total assets $-0- $16,417 $-0- $16,417
==== ======= ==== =======
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accrued expenses $-0- $36,417 $36,417
---- ------- -------
Total current liabilities -0- 36,417 36,417
Stockholders' equity
Common Stock authorized 2,000,000 89,110 89,110
shares, no-par value each. At
November 30, 1998, there are
1,700,000 shares outstanding
Deficit accumulated during (109,110) (109,110)
development stage -------- --------
Total stockholders' equity (20,000) (20,000)
------- -------
Total liabilities and $-0- $16,417 $-0- $16,417
stockholders' equity ==== ======= ==== =======
See accompanying notes to pro forma financial statements.
F2
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
PRO FORMA STATEMENT OF OPERATIONS
FOR THE PERIOD FROM INCEPTION, , 1998, TO NOVEMBER 30, 1998
Senesco, Inc. Senesco, LLC Adjustments Senesco, Inc.
------------- ------------ ----------- -------------
Revenue $-0- $-0- $-0-
Costs of goods sold -0- -0- -0-
Gross profit -0- -0- -0-
Operations:
General and administrative -0- 109,110 109,110
Depreciation and amortization -0- -0- -0-
--- -------- --------
Total expense -0- 109,110 109,110
Income (loss) -0- (109,110) (109.110)
==== ======== ========
Net income (loss) per share-basic $(.06) $(.06)
========= ==========
Number of shares outstanding-basic 1,700,000 1,700,000
========= =========
See accompanying notes to pro forma financial statements.
F3
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
PRO FORMA STATEMENT OF CASH FLOWS
FOR THE PERIOD FROM INCEPTION, , 1998, TO NOVEMBER 30, 1998
Senesco, Senesco, Senesco,
Inc. LLC Adjustments Inc.
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) $-0- $(109,110) $(109,110)
Depreciation -0- -0-
Adjustments to reconcile net income (loss) to net cash
Accrued expenses 36,417 36,417
TOTAL CASH FLOWS FROM OPERATIONS -0- (72,693) (72,693)
CASH FLOWS FROM INVEST1NG ACTIVITIES
Patent costs (16,417) (16,417)
-------- --------
TOTAL CASH FLOWS FROM INVESTING ACTIVITIES -0- (16,417) (16,417)
CASH FLOWS FROM FINANCING ACTIVITIES
Members' equity contribution 89,110 89,110
------ ------
TOTAL CASH FLOWS FROM FINANCING ACTIVITIES -0- 89,110 89,110
NET INCREASE (DECREASE) IN CASH -0- -0- -0-
CASH BALANCE BEGINNING OF PERIOD -0- -0- -0-
CASH BALANCE END OF PERIOD $-0- $-0- $-0-
====== ====== ======
See accompanying notes to pro forma financial statements.
F4
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
PRO FORMA STATEMENT OF STOCKHOLDERS EQUITY
Deficit accumulated
Common Common during development
Date Stock Stock stage Total
- ---- ----- ----- ----- -----
11-30-1998 1,700,000 $89,110 $(109,110) $(20,000)
========= ======= ========== =========
See accompanying notes to pro forma financial statements.
F5
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO PRO FORMA FINANCIAL STATEMENTS
NOVEMBER 30, 1998
NOTE 1. ORGANIZATION OF COMPANY AND ISSUANCE OF COMMON STOCK
----------------------------------------------------
a. Creation of the Company
Senesco, Inc., (the "Company") was formed under the laws of New Jersey on
November 25, 1998 and is authorized to issue 2,00,000 shares of common stock,
no-par value each.
b. Description of the Company
The Company is a development stage company that was organized as a
predecessor to Senesco, LLC ("Senesco") to commercially exploit technology
acquired and developed in connection with the identification and
characterization of a gene which controls the aging of of fruits, vegetables and
flowers.
c. Issuance of Shares of Common Stock
On November 30, 1998, the Company issued 1,700,000 shares of common stock
to the Members of Senesco in exchange for Senesco's assets and the interests and
rights to Senesco's technologies and patents. The transaction was treated using
the pooling of interest method of accounting with historic costs being the basis
of the transfer of account balances to the Company.
NOTE 2-SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
------------------------------------------
a. Basis of Financial Statement Presentation
The accompanying proforma financial statements have been prepared on a
going concern basis, which contemplates the realization of assets and the
satisfaction of liabilities in the normal course of business. On June 25, 1998,
Senesco acquired a certain patent application. Neither the Company or Senesco
has generated any income and has been dependent upon management to pay the
expenses to maintain the Company's existence and pay the costs of acquiring the
patent. These factors indicate that the Company's continuation as a going
concern is dependent upon its ability to obtain adequate financing.
The proforma financial statements presented consist of the balance sheet of
the Company as at November 30, 1998 and the related statements of operations,
members' capital and cash flows for the period from inception, November 25,
1998, to November 30, 1998.
b. Cash and cash equivalents
The Company treats temporary investments with a maturity of less than three
months as cash.
c. Revenue recognition
Revenue is recognized when products are shipped or services are
rendered.
F6
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO PRO FORMA FINANCIAL STATEMENTS
NOVEMBER 30, 1998
d. Selling and Marketing Costs
Selling and Marketing - Certain selling and marketing costs are expensed in
the period in which the cost pertains. Other selling and marketing costs are
expensed as incurred.
e. Use of Estimates
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that effect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
f. Asset Impairment
The Company adopted the provisions of SFAS No. 121, Accounting for the
impairment of long lived assets and for long-lived assets to be disposed of
effective January 1, 1996. SFAS No. 121 requires impairment losses to be
recorded on long-lived assets used in operations when indicators of impairment
are present and the estimated undiscounted cash flows to be generated by those
assets are less than the assets' carrying amount. SFAS No. 121 also addresses
the accounting for long-lived assets that are expected to be disposed of. There
was no effect of such adoption on the Company's financial position or results of
operations.
g. Research and Development Expenses
Research and development expenses are charged to operations when incurred.
h. Patent Costs
Costs incurred to acquire exclusive licenses of patentable technology
are capitalized and amortized over the shorter of a five year period or the term
of the license or patent. The portion of these amounts determined to be
attributable to patents is amortized over their remaining lives and the
remainder is amortized over the estimated period of benefit but not more than 40
years on a straight line basis.
NOTE 3 - TRANSFER OF ASSETS
The Company entered into an Agreement and Plan of Merger (the "Agreement"),
with Senesco, pursuant to which the Company exchanged all the membership
interests in Senesco for an aggregate of 1,700,000 shares of common stock of the
Company. The shares of common stock were divided amongst the Members of Senesco
in the same ratio as the Membership interests. Mr. Phillippe Escaravage is the
President of Senesco, Inc.
The transaction has been accounted for as a transfer and is accounted for
at historical cost as a pooling of interests with the recording of the net
assets acquired at their historical book value.
F7
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO PRO FORMA FINANCIAL STATEMENTS
NOVEMBER 30, 1998
On October 2, 1998, the Company entered into a Letter of Intent with Nava
Leisure USA Inc. ("Leisure"), pursuant to which Leisure would acquire the
assets of the Company through Leisure's subsidiary Nava Leisure Acquisition
Corp. ("Acquisition Corp.") in exchange for 1,700,000 shares of Leisure's common
stock. Acquisition Corp. would be the surviving entity.
As part of the agreement, the Company was to transfer its assets including
the Company's patents, technologies and related agreements from Senesco.
NOTE 4 - MARKETABLE SECURITIES, AVAILABLE FOR SALE
The Company adopted Financial Accounting Standards Board ("FASB") Statement
No. 115, "Accounting for Certain Investments in Debt and Equity Securities",
which requires that investments in equity securities that have readily
determinable fair values and investments in debt securities be classified in
three categories: held-to-maturity, trading and available-for-sale. Based on the
nature of the assets held by the Company and Management's investment strategy,
the Company's investments have been classified as available-for-sale. Management
determines the appropriate classification of debt securities at the time of
purchase and reevaluates such designation as of each balance sheet date.
Securities classified as available-for-sale are carried at estimated fair
value, as determined by quoted market prices, with unrealized gains and losses,
net of tax, reported in a separate component of stockholders' equity. At
October 31, 1998, the Company had no investments that were classified as
trading or held-to-maturity as defined by the Statement.
NOTE 5 - RELATED PARTY TRANSACTIONS
--------------------------
a. Transfer of Patent
On June 25, 1998, John E. Thompson, Yuwen Hong and Katalin A. Hudak filed a
U.S. Patent Application in connection with the identification and
characterization of a gene which controls the aging of plants. On June 25, 1998,
these individuals assigned their ownership of the patent to this technology
including current and future patents to Senesco in exchange for Membership as
follows: John E. Thompson, 25%; Yuwen Hong, 1% and Katalin A. Hudak, 1 %.
b. Member Contribution
Mr. Phillippe Escaravage caused to be paid on behalf of Senesco, $89,110 in
expenses of Senesco for the period from inception, June 25, 1998, to October 31,
1998. This contributed amount was treated as an increase in Members' Equity in
Senesco.
c. Common Management
Mr. Phillippe Escaravage is the Managing Member of the Company, President
of Escaravage Biological Industries, LLC. and President of Senesco.
F8
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO PRO FORMA FINANCIAL STATEMENTS
NOVEMBER 30, 1998
NOTE 6 - COMMITMENTS AND CONTINGENCIES
The Company has acquired through the acquisition of Senesco certain
relationships as follows:
a. Consulting Services
Senesco has accrued $20,000 in consulting fees due Mr. Steven Katz, a
Member, as of October 31, 1998.
b. Consulting Agreement
On June 26, 1998, the Senesco entered into a 3 year exclusive research and
development Consulting Agreement, beginning July 1, 1998, with Dr. John E.
Thompson, Dean of Science at the University of Waterloo, Waterloo, Ontario. The
Consulting Agreement is automatically renewable for 2 additional three-year
terms, unless either of the parties notifies the other with written notice. The
Company is obligated to reimbuse Dr. Thompson for reasonable traveling and
living expenses. Mr. Thompson has agreed to not compete and to assign to the
Company his entire right, title and interest to any inventions or improvements
during the course of this agreement and for a period of 1 year after the
conclusion of this agreement. Dr. Thompson has also agreed to act as an
independent contractor and is not eligible to participate in any benefits
extended by the Company to its employees.
c. Lease of Office Space
The Company subleases office space at 11 Chambers Street, Princeton, New
Jersey from Escaravage Biological Industries, LLC at $400 per month on a month
to month lease.
NOTE 7 - SUBSEQUENT EVENTS
Research Agreement
Subsequent to the date of the financial statements, Senesco entered into a
research agreement with the University of Waterloo, Waterloo, Ontario, Canada,
("Waterloo"), pursuant to which Dr. Thompson will utilize the facilities and
staff at Waterloo University to perform research and development services under
the guidance of Dr. Thompson. Waterloo agrees to assign to Sernesco and the
Company all rights, title and interest to any technology and inventions made,
conceived of or arising this agreement.
NOTE 8 - INCOME TAXES
------------
The Company provides for the tax effects of transactions reported in the
financial statements. The provision if any, consists of taxes currently due plus
deferred taxes related primarily to differences between the basis of assets and
liabilities for financial and income tax reporting. The deferred tax assets and
liabilities, if any represent the future tax return consequences of those
differences, which will either be taxable or deductible when the assets and
liabilities are recovered or settled. As of November 30, 1998, the Company had
no material
F9
SENESCO, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO PRO FORMA FINANCIAL STATEMENTS
NOVEMBER 30, 1998
current tax liability, deferred tax assets, or liabilities to impact on the
Company's financial position because the deferred tax asset related to the
Company's net operating loss carryforward and was fully offset by a valuation
allowance.
At November 30, 1998, the Company has net operating loss carry forwards for
income tax purposes of $109,110. This carryforward is available to offset future
taxable income, if any, and expires in the year 2010. The Company's utilization
of this carryforward against future taxable income may become subject to an
annual limitation due to a cumulative change in ownership of the Company of more
than 50 percent.
The components of the net deferred tax asset as of November 30, 1998 are as
follows:
Deferred tax asset:
Net operating loss carry forward $ 37,097
Valuation allowance $(37,097)
--------
Net deferred tax asset $ -0-
========
The Company recognized no income tax benefit for the loss generated in the
period from inception, November 25, 1998 to November 30, 1998.
SFAS No. 109 requires that a valuation allowance be provided if it is more
likely than not that some portion or all of a deferred tax asset will not be
realized. The Company's ability to realize benefit of its deferred tax asset
will depend on the generation of future taxable income. Because the Company has
yet to recognize significant revenue from the sale of its products, the Company
believes that a full valuation allowance should be provided.
F10
NAVA LEISURE USA, INC.
1998 STOCK INCENTIVE PLAN
1. Purposes of the Plan. The purposes of this Plan are to attract and
--------------------
retain the best available personnel for positions of substantial responsibility,
to provide additional incentive to Employees, non-Employee members of the Board
and Consultants of the Company and its Subsidiaries and to promote the success
of the Company's business. Options granted under the Plan may be incentive stock
options (as defined under Section 422 of the Code) or non-statutory stock
options, as determined by the Administrator at the time of grant of an option
and subject to the applicable provisions of Section 422 of the Code, as amended,
and the regulations promulgated thereunder. Stock purchase rights may also be
granted under the Plan.
2. Certain Definitions. As used herein, the following definitions shall
-------------------
apply:
(a) "Administrator" means the Board or any of its Committees
------------
appointed pursuant to Section 4 of the Plan.
(b) "Board" means the Board of Directors of the Company.
-----
(c) "Code" means the Internal Revenue Code of 1986, as amended.
----
(d) "Committee" means the Committee appointed by the Board of
---------
Directors in accordance with paragraph (a) of Section 4 of the Plan.
(e) "Common Stock" means the Common Stock of the Company.
------------
(f) "Company" means Nava Leisure USA, Inc., an Idaho corporation.
-------
(g) "Consultant" means any person, including an advisor, who is
----------
engaged by the Company or any Parent or subsidiary to render services and is
compensated for such services, and any director of the Company whether
compensated for such services or not .
(h) "Continuous Status as an Employee" means the absence of any
--------------------------------
interruption or termination of the employment relationship by the Company or any
Subsidiary. Continuous Status as an Employee shall not be considered interrupted
in the case of: (i) sick leave; (ii) military leave; (iii) any other leave of
absence approved by the Board, provided that such leave is for a period of not
more than ninety (90) days, unless reemployment upon the expiration of such
leave is guaranteed by contract or statute, or unless provided otherwise
pursuant to Company policy adopted from time to time; or (iv) transfers between
locations of the Company or between the Company, its Subsidiaries or its
successor.
(i) "Employee" means any person, including officers and directors,
--------
employed by the Company or any Parent or Subsidiary of the Company. The payment
of a director's fee by the Company shall not be sufficient to constitute
"employment" by the Company.
(j) "Exchange Act" means the Securities Exchange Act of 1934, as
------------
amended.
(k) "Fair Market Value" means, as of any date, the value of Common
-----------------
Stock determined as follows:
(i) If the Common Stock is listed on any established stock
exchange or a national market system including without limitation the
National Market System of the National Association of Securities Dealers,
Inc. Automated Quotation ("Nasdaq") System, its Fair Market Value shall be
the closing sales price for such stock (or the closing bid, if no sales
were reported) as quoted on such system or exchange for the last market
trading day prior to the time of determination as reported in the Wall
Street Journal or such other source as the Administrator deems reliable or;
(ii) If the Common Stock is quoted on Nasdaq (but not on the
National Market System thereof) or regularly quoted by a recognized
securities dealer but selling prices are not reported, its Fair Market
Value shall be the mean between the high and low asked prices for the
Common Stock or;
(iii) In the absence of an established market for the Common
Stock, the Fair Market Value thereof shall be determined in good faith by
the Administrator.
(l) "Incentive Stock Option" means an Option intended to qualify as
----------------------
an incentive stock option within the meaning of Section 422 of the Code.
(m) "Nonstatutory Stock Option" means an Option not intended to
-------------------------
qualify as an Incentive Stock Option.
(n) "Option" means a stock option granted pursuant to the Plan.
------
(o) "Optioned Stock" means the Common Stock subject to an Option.
--------------
(p) "Optionee" means an Employee or Consultant who receives an
--------
Option.
(q) "Parent" means a "parent corporation", whether now or hereafter
------
existing, as defined in Section 424(e) of the Code.
(r) "Plan" means this 1998 Stock Incentive Plan.
----
(s) "Restricted Stock" means shares of Common Stock acquired pursuant
----------------
to a grant of stock purchase rights under Section 11 below.
(t) "Share" means a share of the Common Stock, as adjusted in
-----
accordance with Section 13 of the Plan.
(u) "Subsidiary" means a "subsidiary corporation", whether now or
----------
hereafter existing, as defined in Section 424(f) of the Code.
-2-
3. Stock Subject to the Plan. Subject to the provisions of Section 13 of
-------------------------
the Plan, the maximum aggregate number of shares which may be optioned and sold
under the Plan is five hundred thousand (500,000) shares of Common Stock. The
shares may be authorized, but unissued, or reacquired Common Stock.
If an option should expire or become unexercisable for any reason
without having been exercised in full, the unpurchased Shares which were subject
thereto shall, unless the Plan shall have been terminated, become available for
future grant under the Plan.
4. Administration of the Plan.
--------------------------
(a) Procedure.
---------
(i) Administration With Respect to Directors and Officers.
-----------------------------------------------------
With respect to grants of Options or stock purchase rights to Employees who
are also officers or directors of the Company, the Plan shall be
administered by (A) the Board, if the Board may administer the Plan in
compliance with Rule 16b-3 promulgated under the Exchange Act or any
successor thereto ("Rule 16b-3") with respect to a plan intended to allow
transactions between the Company and the Optionee to be exempt for Section
16(b) of the Exchange Act, or (B) a Committee designated by the Board to
administer the Plan, which Committee shall be constituted in such a manner
as to permit the Plan to comply with Rule 16b-3 with respect to a plan
intended to allow transactions between the Company and the Optionee to be
exempt for Section 16(b) of the Exchange Act. Once appointed, such
Committee shall continue to serve in its designated capacity until
otherwise directed by the Board. From time to time the Board may increase
the size of the Committee and appoint additional members thereof, remove
members (with or without cause) and appoint new members in substitution
therefor, fill vacancies, however caused, and remove all members of the
Committee and thereafter directly administer the Plan, all to the extent
permitted by Rule 16b-3 with respect to a plan intended to qualify
thereunder as a discretionary plan.
(ii) Multiple Administrative Bodies. If permitted by Rule
------------------------------
16b-3, the Plan may be administered by different bodies with respect to
directors, non-director officers and Employees who are neither directors
nor officers.
(iii) Administration With Respect to Consultants and Other
----------------------------------------------------
Employees. With respect to grants of Options or stock purchase rights to
---------
Employees who are neither directors nor officers of the Company or to
Consultants, the Plan shall be administered by (A) the Board, if the Board
may administer the Plan in compliance with Rule 16b-3, or (B) a Committee
designated by the Board, which Committee shall be constituted in such a
manner as to satisfy the legal requirements relating to the administration
of incentive stock option plans, if any, of Idaho corporate law and
applicable securities laws and of the Code (the "Applicable Laws"). Once
appointed, such Committee shall continue to serve in its designated
capacity until otherwise directed by the Board. From time to time the Board
may increase the size of the Committee and appoint additional members
-3-
thereof, remove members (with or without cause) and appoint new members in
substitution therefor, fill vacancies, however caused, and remove all
members of the Committee and thereafter directly administer the Plan, all
to the extent permitted by the Applicable Laws.
(b) Powers of the Administrator. Subject to the provisions of the
---------------------------
Plan and in the case of a Committee, the specific duties delegated by the Board
to such Committee, the Administrator shall have the authority, in its
discretion:
(i) to determine the Fair Market Value of the Common Stock,
in accordance with Section 2(k) of the Plan;
(ii) to select the officers, Consultants and Employees to whom
Options and stock purchase rights may from time to time be granted
hereunder;
(iii) to determine whether and to what extent Options and stock
purchase rights or any combination thereof, are granted hereunder;
(iv) to determine the number of shares of Common Stock to be
covered by each such award granted hereunder;
(v) to approve forms of agreement for use under the Plan;
(vi) to determine the terms and conditions, not inconsistent
with the terms of the Plan, of any award granted hereunder (including, but
not limited to, the share price and any restriction or limitation or waiver
of forfeiture restrictions regarding any Option or other award and/or the
shares of Common Stock relating thereto, based in each case on such factors
as the Administrator shall determine, in its sole discretion);
(vii) to determine whether and under what circumstances an
Option may be settled in cash under subsection 9(f) instead of Common
Stock;
(viii) to determine whether, to what extent and under what
circumstances Common Stock and other amounts payable with respect to an
award under this Plan shall be deferred either automatically or at the
election of the participant (including providing for and determining the
amount, if any, of any deemed earnings on any deferred amount during any
deferral period);
(xi) to reduce the exercise price of any Option to the then
current Fair Market Value if the Fair Market Value of the Common Stock
covered by such Option shall have declined since the date the Option was
granted; and
(x) to determine the terms and restrictions applicable to
stock purchase rights and the Restricted Stock purchased by exercising such
stock purchase rights.
-4-
(c) Effect of Committee's Decision. All decisions, determinations
------------------------------
and interpretations of the Administrator shall be final and binding on all
Optionees and any other holders of any Options.
5. Eligibility.
-----------
(a) Nonstatutory Stock Options may be granted to Employees and
Consultants. Incentive Stock Options may be granted only to Employees. An
Employee or Consultant who has been granted an Option may, if he is otherwise
eligible, be granted an additional Option or Options.
(b) Each Option shall be designated in the written option agreement
as either an Incentive Stock Option or a Nonstatutory Stock Option. However,
notwithstanding such designations, to the extent that the aggregate Fair Market
Value of the Shares with respect to which Options designated as Incentive Stock
Options are exercisable for the first time by any optionee during any calendar
year (under all plans of the Company or any Parent or Subsidiary) exceeds
$100,000, such excess Options shall be treated as Nonstatutory Stock Options.
(c) For purposes of Section 5(b), Incentive Stock Options shall be
taken into account in the order in which they were granted, and the Fair Market
Value of the Shares shall be determined as of the time the Option with respect
to such Shares is granted.
(d) The Plan shall not confer upon any Optionee any right with
respect to continuation of employment or consulting relationship with the
Company, nor shall it interfere in any way with his right or the Company's right
to terminate his employment or consulting relationship at any time, with or
without cause.
6. Term of Plan. The Plan shall become effective upon the earlier to
------------
occur of its adoption by the Board of Directors or its approval by the
shareholders of the Company as described in Section 19 of the Plan. It shall
continue in effect for a term of ten (10) years unless sooner terminated under
Section 15 of the Plan.
-5-
7. Term of Option. The term of each Option shall be the term stated in
--------------
the Option Agreement; provided, however, that in the case of an Incentive Stock
Option, the term shall be no more than ten (10) years from the date of grant
thereof or such shorter term as may be provided in the Option Agreement.
However, in the case of an Option granted to an Optionee who, at the time the
Option is granted, owns stock representing more than ten percent (10%) of the
voting power of all classes of stock of the Company or any Parent or Subsidiary,
the term of the Option shall be five (5) years from the date of grant thereof or
such shorter term as may be provided in the Option Agreement.
(8) Option Exercise Price and Consideration.
---------------------------------------
(a) The per share exercise price for the Shares to be issued pursuant
to exercise of an Option shall be such price as is determined by the Board, but
shall be subject to the following:
(i) In the case of an Incentive Stock Option
(A) granted to an Employee who, at the time of the grant of
such Incentive Stock Option, owns stock representing more than ten percent
(10%) of the voting power of all classes of stock of the Company or any
Parent or Subsidiary, the per Share exercise price shall be no less than
110% of the Fair Market Value per Share on the date of grant.
(B) granted to any Employee, the per Share exercise price
shall be no less than 100% of the Fair Market Value per Share on the date
of grant.
(ii) In the case of a Nonstatutory Stock Option
(A) granted to a person who, at the time of the grant of
such Option, owns stock representing more than ten percent (10%) of the
voting power of all classes of stock of the Company or any Parent or
Subsidiary, the per Share exercise price shall be no less than 110% of the
Fair Market Value per Share on the date of the grant.
(B) granted to any person, the per Share exercise price
shall be no less than 85% of the Fair Market Value per Share on the date of
grant.
(b) The consideration to be paid for the Shares to be issued upon
exercise of an Option, including the method of payment, shall be determined by
the Administrator (and, in the case of an Incentive Stock Option, shall be
determined at the time of grant) and may consist entirely of (1) cash, (2)
check, (3) promissory note, (4) other Shares which (x) in the case of Shares
acquired upon exercise of an Option either have been owned by the Optionee for
more than six months on the date of surrender or were not acquired, directly or
indirectly, from the Company, and (y) have a Fair Market Value on the date of
surrender equal to the aggregate exercise price of the Shares as to which said
Option shall be exercised, (5) authorization from the Company to retain from the
total number of Shares as to which the Option is exercised that number of Shares
having a Fair Market Value on the date of exercise equal to the exercise price
-6-
for the total number of Shares as to which the option is exercised, (6) delivery
of a properly executed exercise notice together with irrevocable instructions to
a broker to promptly deliver to the Company the amount of sale or loan proceeds
required to pay the exercise price, (7) by delivering an irrevocable
subscription agreement for the Shares which irrevocably obligates the option
holder to take and pay for the Shares not more than twelve months after the date
of delivery of the subscription agreement, (8) any combination of the foregoing
methods of payment, or (9) such other consideration and method of payment for
the issuance of Shares to the extent permitted under Applicable Laws. In making
its determination as to the type of consideration to accept, the Administrator
shall consider if acceptance of such consideration may be reasonably expected to
benefit the Company.
9. Exercise of Option.
------------------
(a) Procedure for Exercise; Rights as a Shareholder. Any Option
-----------------------------------------------
granted hereunder shall be exercisable at such times and under such conditions
as determined by the Administrator, including performance criteria with respect
to the Company and/or the Optionee, and as shall be permissible under the terms
of the Plan.
An Option may not be exercised for a fraction of a Share.
An Option shall be deemed to be exercised when written notice of
such exercise has been given to the Company in accordance with the terms of the
Option by the person entitled to exercise the Option and full payment for the
Shares with respect to which the Option is exercised has been received by the
Company. Full payment may, as authorized by the Administrator, consist of any
consideration and method of payment allowable under Section 8(b) of the Plan.
Until the issuance (as evidenced by the appropriate entry on the books of the
Company or of a duly authorized transfer agent of the Company) of the stock
certificate evidencing such Shares, no right to vote or receive dividends or any
other rights as a shareholder shall exist with respect to the Optioned Stock,
notwithstanding the exercise of the Option. The Company shall issue (or cause to
be issued) such stock certificate promptly upon exercise of the Option. No
adjustment will be made for a dividend or other right for which the record date
is prior to the date the stock certificate is issued, except as provided in
Section 11 of the Plan.
Exercise of an Option in any manner shall result in a decrease in
the number of Shares which thereafter may be available, both for purposes of the
Plan and for sale under the Option, by the number of Shares as to which the
Option is exercised.
(b) Termination of Employment. In the event of termination of an
-------------------------
Optionee's consulting relationship or Continuous Status as an Employee with the
Company (as the case may be), such Optionee may, but only within ninety (90)
days (or such other period of time as is determined by the Board, with such
determination in the case of an Incentive Stock Option being made at the time of
grant of the Option and not exceeding ninety (90) days) after the date of such
termination (but in no event later than the expiration date of the term of such
Option as set forth in the Option Agreement), exercise his Option to the extent
that Optionee was entitled to exercise it at the date of such termination. To
the extent that Optionee was not entitled to exercise the
-7-
Option at the date of such termination, or if Optionee does not exercise such
Option to the extent so entitled within the time specified herein, the Option
shall terminate.
(c) Disability of Optionee. Notwithstanding the provisions of
----------------------
Section 9(b) above, in the event of termination of an Optionee's consulting
relationship or Continuous Status as an Employee as a result of his total and
permanent disability (as defined in Section 22(e)(3) of the Code), Optionee may,
but only within twelve (12) months from the date of such termination (but in no
event later than the expiration date of the term of such Option as set forth in
the Option Agreement), exercise the Option to the extent otherwise entitled to
exercise it at the date of such termination. To the extent that Optionee was not
entitled to exercise the Option at the date of termination, or if Optionee does
not exercise such Option to the extent so entitled within the time specified
herein, the Option shall terminate.
(d) Death of Optionee. In the event of the death of an Optionee, the
-----------------
Option may be exercised, at any time within twelve (12) months following the
date of death (but in no event later than the expiration date of the term of
such Option as set forth in the Option Agreement), by the Optionee's estate or
by a person who acquired the right to exercise the Option by bequest or
inheritance, but only to the extent the Optionee was entitled to exercise the
Option at the date of death. To the extent that Optionee was not entitled to
exercise the Option at the date of termination, or if Optionee does not exercise
such Option to the extent so entitled within the time specified herein, the
Option shall terminate.
(e) Rule 16b-3. Options granted to persons subject to Section 16(b)
----------
of the Exchange Act must comply with Rule 16b-3 and shall contain such
additional conditions or restrictions as may be required thereunder to qualify
for the maximum exemption from Section 16 of the Exchange Act with respect to
Plan transactions.
(f) Buyout Provisions. The Administrator may at any time offer to
buy out for a payment in cash or Shares, an Option previously granted, based on
such terms and conditions as the Administrator shall establish and communicate
to the Optionee at the time that such offer is made.
10. Non-Transferability of Options. The Option may not be sold, pledged,
------------------------------
assigned, hypothecated, transferred, or disposed of in any manner other than by
will or by the laws of descent or distribution and may be exercised, during the
lifetime of the Optionee, only by the Optionee. The terms of the Option shall
be binding upon the executors, administrators, heirs, successors and assigns of
the Optionee.
-8-
11. Stock Purchase Rights.
---------------------
(a) Rights to Purchase. Stock purchase rights may be issued either
------------------
alone, in addition to, or in tandem with other awards granted under the Plan
and/or cash awards made outside of the Plan. After the Administrator determines
that it will offer stock purchase rights under the Plan, it shall advise the
offeree in writing of the terms, conditions and restrictions related to the
offer, including the number of Shares that such person shall be entitled to
purchase, the price to be paid (which price shall not be less than 50% of the
Fair Market Value of the Shares as of the date of the offer), and the time
within which such person must accept such offer, which shall in no event exceed
thirty (30) days from the date upon which the Administrator made the
determination to grant the stock purchase right. The offer shall be accepted by
execution of a Restricted Stock purchase agreement in the form determined by the
Administrator.
(b) Repurchase Option. Unless the Administrator determines
-----------------
otherwise, the Restricted Stock purchase agreement shall grant the Company a
repurchase option exercisable upon the voluntary or involuntary termination of
the purchaser's employment with the Company for any reason (including death or
Disability). The purchase price for Shares repurchased pursuant to the
Restricted Stock purchase agreement shall be the original price paid by the
purchaser and may be paid by cancellation of any indebtedness of the purchaser
to the Company. The repurchase option shall lapse at such rate as the Committee
may determine.
(c) Other Provisions. The Restricted Stock purchase agreement shall
----------------
contain such other terms, provisions and conditions not inconsistent with the
Plan as may be determined by the Administrator in its sole discretion. In
addition, the provisions of Restricted Stock purchase agreements need not be the
same with respect to each purchaser.
(d) Rights as a Shareholder. Once the stock purchase right is
-----------------------
exercised, the purchaser shall have the rights equivalent to those of a
shareholder, and shall be a shareholder when his or her purchase is entered upon
the records of the duly authorized transfer agent of the Company. No adjustment
will be made for a dividend or other right for which the record date is prior to
the date the stock purchase right is exercised, except as provided in Section 13
of the Plan.
12. Stock Withholding to Satisfy Withholding Tax Obligations. At the
--------------------------------------------------------
discretion of the Administrator, Optionees may satisfy withholding obligations
as provided in this paragraph. When an Optionee incurs tax liability in
connection with an Option or stock purchase right, which tax liability is
subject to tax withholding under applicable tax laws, and the Optionee is
obligated to pay the Company an amount required to be withheld under applicable
tax laws, the Optionee may satisfy the withholding tax obligation by electing to
have the Company withhold
-9-
from the Shares to be issued upon exercise of the Option, or the Shares to be
issued in connection with the stock purchase right, if any, that number of
Shares having a Fair Market Value equal to the amount required to be withheld.
The Fair Market Value of the Shares to be withheld shall be determined on the
date that the amount of tax to be withheld is to be determined (the "Tax Date").
All elections by an Optionee to have Shares withheld for this purpose
shall be made in writing in a form acceptable to the Administrator and shall be
subject to the following restrictions:
(a) the election must be made on or prior to the applicable Tax Date;
(b) once made, the election shall be irrevocable as to the particular
Shares of the Option or Right as to which the election is made;
(c) all elections shall be subject to the consent or disapproval of
the Administrator;
(d) if the Optionee is subject to Rule 16b-3, the election must
comply with the applicable provisions of Rule 16b-3 and shall be subject to such
additional conditions or restrictions as may be required thereunder to qualify
for the maximum exemption from Section 16 of the Exchange Act with respect to
Plan transactions.
In the event the election to have Shares withheld is made by an
Optionee and the Tax Date is deferred under Section 83 of the Code because no
election is filed under Section 83(b) of the Code, the Optionee shall receive
the full number of Shares with respect to which the Option or stock purchase
right is exercised but such Optionee shall be unconditionally obligated to
tender back to the Company the proper number of Shares on the Tax Date.
13. Adjustments Upon Changes in Capitalization or Merger. Subject to any
----------------------------------------------------
required action by the shareholders of the Company, the number of shares of
Common Stock covered by each outstanding Option, and the number of shares of
Common Stock which have been authorized for issuance under the Plan but as to
which no Options have yet been granted or which have been returned to the Plan
upon cancellation or expiration of an Option, as well as the price per share of
Common Stock covered by each such outstanding Option, shall be proportionately
adjusted for any increase or decrease in the number of issued shares of Common
Stock resulting from a stock split, reverse stock split, stock dividend,
combination or reclassification of the Common Stock, or any other increase or
decrease in the number of issued shares of Common Stock effected without receipt
of consideration by the Company; provided, however, that conversion of any
convertible securities of the Company shall not be deemed to have been "effected
without receipt of consideration." Such adjustment shall be made by the Board,
whose determination in that respect shall be final, binding and conclusive.
Except as expressly provided herein, no issuance by the Company of shares of
stock of any class, or securities convertible into shares of stock of any class,
shall affect, and no adjustment by reason
-10-
thereof shall be made with respect to, the number or price of shares of Common
Stock subject to an Option.
In the event of the proposed dissolution or liquidation of the
Company, the Board shall notify the Optionee at least fifteen (15) days prior to
such proposed action. To the extent it has not been previously exercised, the
Option will terminate immediately prior to the consummation of such proposed
action. In the event of a merger or consolidation of the Company with or into
another corporation or the sale of all or substantially all of the Company's
assets (hereinafter, a "merger"), the Option shall be assumed or an equivalent
option shall be substituted by such successor corporation or a parent or
subsidiary of such successor corporation. In the event that such successor
corporation does not agree to assume the Option or to substitute an equivalent
option, the Board shall, in lieu of such assumption or substitution, provide for
the Optionee to have the right to exercise the Option as to all of the Optioned
Stock, including Shares as to which the Option would not otherwise be
exercisable. If the Board makes an Option fully exercisable in lieu of
assumption or substitution in the event of a merger, the Board shall notify the
Optionee that the Option shall be fully exercisable for a period of fifteen (15)
days from the date of such notice, and the Option will terminate upon the
expiration of such period. For the purposes of this paragraph, the Option shall
be considered assumed if, following the merger, the Option or right confers the
right to purchase, for each Share of stock subject to the Option immediately
prior to the merger, the consideration (whether stock, cash, or other securities
or property) received in the merger by holders of Common Stock for each Share
held on the effective date of the transaction (and if holders were offered a
choice of consideration, the type of consideration chosen by the holders of a
majority of the outstanding Shares); provided, however, that if such
consideration received in the merger was not solely common stock of the
successor corporation or its Parent, the Board may, with the consent of the
successor corporation and the participant, provide for the consideration to be
received upon the exercise of the Option, for each Share of stock subject to the
Option, to be solely common stock of the successor corporation or its Parent
equal in Fair Market Value to the per share consideration received by holders of
Common Stock in the merger or sale of assets.
14. Time of Granting Options. The date of grant of an Option shall, for
------------------------
all purposes, be the date on which the Administrator makes the determination
granting such Option, or such other date as is determined by the Board. Notice
of the determination shall be given to each Employee or Consultant to whom an
Option is so granted within a reasonable time after the date of such grant.
15. Amendment and Termination of the Plan.
-------------------------------------
(a) Amendment and Termination. The Board may at any time amend,
-------------------------
alter, suspend or discontinue the Plan, but no amendment, alteration, suspension
or discontinuation shall be made which would impair the rights of any Optionee
under any grant theretofore made, without his or her consent. In addition, to
the extent necessary and desirable to comply with Rule 16b-3 under the Exchange
Act or with Section 422 of the Code (or any other applicable law or regulation,
including the requirements of the NASD or an established stock exchange), the
-11-
Company shall obtain shareholder approval of any Plan amendment in such a manner
and to such a degree as required.
(b) Effect of Amendment or Termination. Any such amendment or
----------------------------------
termination of the Plan shall not affect Options already granted and such
Options shall remain in full force and effect as if this Plan had not been
amended or terminated, unless mutually agreed otherwise between the Optionee and
the Board, which agreement must be in writing and signed by the Optionee and the
Company.
16. Conditions Upon Issuance of Shares. Shares shall not be issued
----------------------------------
pursuant to the exercise of an Option unless the exercise of such Option and the
issuance and delivery of such Shares pursuant thereto shall comply with all
relevant provisions of law, including, without limitation, the Securities Act of
1933, as amended, the Exchange Act, the rules and regulations promulgated
thereunder, and the requirements of any stock exchange upon which the Shares may
then be listed, and shall be further subject to the approval of counsel for the
Company with respect to such compliance.
As a condition to the exercise of an Option, the Company may require
the person exercising such Option to represent and warrant at the time of any
such exercise that the Shares are being purchased only for investment and
without any present intention to sell or distribute such Shares if, in the
opinion of counsel for the Company, such a representation is required by any of
the aforementioned relevant provisions of law.
17. Reservation of Shares. The Company, during the term of this Plan,
---------------------
will at all times reserve and keep available such number of Shares as shall be
sufficient to satisfy the requirements of the Plan.
The inability of the Company to obtain authority from any regulatory
body having jurisdiction, which authority is deemed by the Company's counsel to
be necessary to the lawful issuance and sale of any Shares hereunder, shall
relieve the Company of any liability in respect of the failure to issue or sell
such Shares as to which such requisite authority shall not have been obtained.
18. Agreements. Options and stock purchase rights shall be evidenced by
----------
written agreements in such form as the Board shall approve from time to time.
19. Shareholder Approval. Continuance of the Plan shall be subject to
--------------------
approval by the shareholders of the Company within twelve (12) months before or
after the date the Plan is adopted. Such shareholder approval shall be obtained
in the degree and manner required under applicable state and federal law.
-12-
20. Information to Optionees. The Company shall provide to each Optionee,
------------------------
during the period for which such Optionee has one or more Options outstanding,
copies of all annual reports and other information which are provided to all
shareholders of the Company. The Company shall not be required to provide such
information if the issuance of Options under the Plan is limited to key
employees whose duties in connection with the Company assure their access to
equivalent information.
* * * * * * * *
-13-
PROXY
NAVA LEISURE USA, INC.
SOLICITED BY THE BOARD OF DIRECTORS
OF NAVA LEISURE USA, INC.
The undersigned hereby appoints ____________________________________, and
each of them with full power of substitution, to vote all shares of Common
Stock, par value $.0005 per share, of Nava Leisure USA, Inc. that the
undersigned is entitled to vote at the Special Meeting of Shareholders thereof
to be held on November 9, 1998 and at any adjournments and postponements
thereof, as follows:
Any executed proxy which does not designate a vote for any item shall be
deemed to grant authority for any item not designated and will be voted "FOR"
----
any such item.
ALL SHARES WILL BE VOTED AS DIRECTED HEREIN AND, UNLESS OTHERWISE DIRECTED,
WILL BE VOTED "FOR" ALL ITEMS AND "FOR THE ELECTION OF ALL NOMINEES TO THE
----
BOARD OF DIRECTORS. YOU MAY REVOKE THIS PROXY AT ANY TIME PRIOR TO A VOTE
THEREON.
PLEASE MARK YOUR VOTES BY PLACING AN "X" IN THE APPROPRIATE BOX IN EACH ITEM.
---
1. To consider and vote upon a proposal to acquire Senesco, Inc. ("Senesco"),
a New Jersey corporation, through the merger of Senesco with and into Nava
Leisure Acquisition Corp. ("Acquisition Corp."), a wholly-owned subsidiary
of the Company (the "Merger"). In consideration for the agreement of the
Shareholders of Senesco to enter into the Merger, the Company will issue
1,700,000 post-Reverse Split shares of the Company's authorized but
previously unissued Common Stock, on a pro rata, one share-for-one share
--- ----
basis to the shareholders of Senesco as per the terms more completely
described in the accompanying Proxy Statement, Letter of Intent dated
October 2, 1998 between the Company and Senesco (the "Letter of Intent")
and Merger Agreement and Plan of Merger dated October 9, 1998 and amended
as of November ______, 1998 among the Company, Senesco and Acquisition
Corp.
FOR ___ AGAINST ___ ABSTAIN ___
2. To consider and vote upon the proposal to effect a three-for-one reverse
stock split with respect to the Company's outstanding Common Stock;
FOR ___ AGAINST ___ ABSTAIN ___
3. To consider and vote upon a proposal to amend the Articles of Incorporation
of the Company to change the name of the Company to "Senesco Technologies,
Inc." or to a similar name to be approved by the shareholders, in order to
more accurately describe the new business of the Company;
FOR ___ AGAINST ___ ABSTAIN ___
4. (a) To elect the following nominees as Directors of the Company:
Phillippe Escaravage
FOR ___ AGAINST ___ WITHHELD ___
Christopher Forbes
FOR ___ AGAINST ___ WITHHELD ___
Steven Katz
FOR ___ AGAINST ___ WITHHELD ___
(b) To increase the number of members of the Board of Directors from three
(3) members to five (5) members;
FOR ___ AGAINST ___ ABSTAIN ___
5. To consider and vote upon the proposal to amend the By-laws of the Company
to create two classes of directors; Class A to consist of four (4)
directors elected to a one-year term and Class B to consist of one (1)
director appointed to a two-year term;
FOR ___ AGAINST ___ ABSTAIN ___
6. To consider and vote upon the reincorporation of the Company in the State
of Delaware;
FOR ___ AGAINST ___ ABSTAIN ___
7. To ratify the terms of the Bridge Loan, providing up to $500,000 in
financing to support expansion of its operations in the interim period
prior to the completion of a public or private offering of securities,
such bridge financing to be evidenced by a promissory note
bearing interest at an annual rate equal to the prime rate plus 2%;
FOR ___ AGAINST ___ ABSTAIN ___
2
8. Adoption of the Stock Option Plan;
FOR ___ AGAINST ___ ABSTAIN ___
9. To appoint Goldstein Golub & Kessler & Co., P.C. as auditors of the Company
for the fiscal year ending June 30, 1999;
FOR ___ AGAINST ___ ABSTAIN ___
10. To consider and vote upon any and all other business that may properly come
before the Special Meeting of Shareholders;
FOR ___ AGAINST ___ ABSTAIN ___
SIGNATURE(S) ________________________ DATE __________
NOTE: Please sign exactly as name appears hereon. Joint owners should each sign.
When signing as attorney, executor, administrator, trustee or guardian,
please give full title as such.
NAVA LEISURE USA, INC.
PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
3
